Podcasts about oxford astrazeneca

Today's Titan is former chair of the UK's Joint Committee on Vaccination and Immunisation, and a key figure in the Oxford-AstraZeneca vaccine which rolled out during the Covid pandemic. Andrew Pollard tells Chris Smith how vaccines work, how public health bodies decide what to protect us against, and how current technology will shape the future of immunisation... Like this podcast? Please help us by supporting the Naked Scientists

Nghe trọn nội dung sách nói VAXXERS trên ứng dụng Voiz FM: https://voiz.vn/play/2435/ Đây là câu chuyện về một cuộc chạy đua - không phải để cạnh tranh với các loại vắc-xin khác hoặc các nhà khoa học khác, mà là chống lại một loại virus chết người và tàn khốc. Vào ngày 1 tháng 1 năm 2020, Sarah Gilbert, giáo sư ngành vắc-xin tại Đại học Oxford, đã đọc một bài báo về bốn người ở Trung Quốc mắc một chứng viêm phổi kỳ lạ. Trong vòng hai tuần, bà và nhóm của mình đã thiết kế một loại vắc-xin chống lại mầm bệnh mà chưa ai từng thấy trước đây. Chưa đầy 12 tháng sau, việc tiêm chủng đã được triển khai trên toàn thế giới để cứu sống hàng triệu người khỏi COVID-19. Vắc-xin giữ kỷ lục “từ phòng nghiên cứu đến khi ra thị trường” trước đó là vắc-xin quai bị, được phát triển trong bốn năm vào những năm 1960. Nhưng vì khó khăn trong việc gây quỹ cho nghiên cứu vắc-xin và các rào cản khác nhau trong quản lý, phải mất 10 năm để hầu hết các loại vắc-xin mới được cấp phép, và thậm chí sau đó, chỉ một thông cáo báo chí vội vã hoặc một nhận xét sai lầm của một chính trị gia có thể nhanh chóng khiến mọi công việc khó khăn trước đó bị đổ xuống sông xuống biển. Trong cuốn sách này, chúng ta được nghe trực tiếp từ Giáo sư Gilbert và đồng nghiệp của bà, Tiến sĩ Catherine Green, khi họ tiết lộ câu chuyện về việc điều chế vắc-xin Oxford AstraZeneca cũng như thứ khoa học tiên tiến và công việc cực kỳ chăm chỉ để tạo ra nó. Trong các chương xen kẽ, được kể từ quan điểm của “Sarah” hoặc “Cath”, các tác giả đã chỉ ra rằng họ không phải là “những hãng dược lớn” mà là hai người bình thường cố gắng đạt được một kỳ tích phi thường trong khi phải đối phó với những căng thẳng hằng ngày khi phải làm mẹ toàn thời gian và trụ cột trong một lĩnh vực nổi tiếng là không an toàn và được trả lương thấp. Đây là câu chuyện của họ khi chiến đấu với đại dịch như những người bình thường trong những hoàn cảnh phi thường. Sarah và Cath chia sẻ những khoảnh khắc thót tim trước cơn bão, họ tách biệt sự thật ra khỏi những điều hư cấu, họ giải thích cách tạo ra một loại vắc-xin an toàn trong thời gian kỷ lục trước sự chứng kiến của cả thế giới và họ cho chúng ta hi vọng vào tương lai. Như Sarah và Catherine chỉ ra, không có cách nào hiệu quả hơn về chi phí để cải thiện tuổi thọ và chất lượng cuộc sống của một người so với một loại vắc-xin chống lại một căn bệnh khó chịu. Tuy nhiên, sự do dự về vắc-xin lại là một vấn đề khác, và nó phản ánh sự quan tâm và lo lắng của họ khi họ dành nhiều đoạn trong cuốn sách của mình để làm sáng tỏ nghiên cứu của họ và đặt những rủi ro của việc tiêm chủng vào hoàn cảnh thực tế. Với cuốn sách này, tác giả sẽ đưa bạn vào phòng thí nghiệm để tìm hiểu xem khoa học sẽ cứu chúng ta như thế nào khỏi đại dịch này và cách chúng ta có thể chuẩn bị cho đại dịch không thể tránh khỏi tiếp theo. Tại ứng dụng sách nói Voiz FM, sách nói VAXXERS được đầu tư chất lượng âm thanh và thu âm chuyên nghiệp, tốt nhất để mang lại trải nghiệm nghe tuyệt vời cho bạn. --- Về Voiz FM: Voiz FM là ứng dụng sách nói podcast ra mắt thị trường công nghệ từ năm 2019. Với gần 2000 tựa sách độc quyền, Voiz FM hiện đang là nền tảng sách nói podcast bản quyền hàng đầu Việt Nam. Bạn có thể trải nghiệm miễn phí đa dạng nội dung tại Voiz FM từ sách nói, podcast đến truyện nói, sách tóm tắt và nội dung dành cho thiếu nhi. --- Voiz FM website: https://voiz.vn/ Theo dõi Facebook Voiz FM: https://www.facebook.com/VoizFM Tham khảo thêm các bài viết review, tổng hợp, gợi ý sách để lựa chọn sách nói dễ dàng hơn tại trang Blog Voiz FM: http://blog.voiz.vn/ --- Cảm ơn bạn đã ủng hộ Voiz FM. Nếu bạn yêu thích sách nói VAXXERS và các nội dung sách nói podcast khác, hãy đăng ký kênh để nhận thông báo về những nội dung mới nhất của Voiz FM channel nhé. Ngoài ra, bạn có thể nghe BẢN FULL ĐỘC QUYỀN hàng chục ngàn nội dung Chất lượng cao khác tại ứng dụng Voiz FM. Tải ứng dụng Voiz FM: voiz.vn/download #voizfm #sáchnói #podcast #sáchnóiVAXXERS #SarahGilbert #CatherineGreen

Professor Sir Andrew Pollard is a world-renowned expert in paediatrics and immunology. From early 2020 he played a leading role in the effort to find a vaccine for the coronavirus. Along with his colleagues at Oxford University, he led the roll out of the Oxford-AstraZeneca vaccine. Andrew tells Peter Leonard about dealing with the stresses of leading such an important project and how he coped doing this under the glare of the world's media. Hosted on Acast. See acast.com/privacy for more information.

The Oxford-Astrazeneca (sic) vaccine has been withdraw globally, with the manufacturer casully citing some "rare but serious" side effects.    BUY ME A COFFEE HERE AND SUPPORT MY WORK ON THIS PODCAST! DO JOIN MY SUBSTACK HERE!   This podcast is sponsored by https://www.quantumhypno.co.uk/  

In January 2021, the first Oxford-Astrazeneca vaccines made their way into people's arms. By mid-march, 11 million people had received the jab.After successive lockdowns, it felt like a way out. But now, more than two years on, storm clouds are gathering.Today, 80 of them are preparing to sue Astrazeneca. They say that until now, no one has wanted to hear their stories. So we're telling them.Find out more: ‘We were told the vaccine was safe - but what happened has been life-changing'Archive used in this episode from: BBC, Sky News, 10 Downing Street.Read more about the Lockdown Files here: www.telegraph.co.uk/news/lockdown-files |For 30 days' free access to The Telegraph: www.telegraph.co.uk/lockdownfilespodcast |If you have any information that could help the investigation, you can email the team on lockdownfiles@telegraph.co.uk |

In January 2021, the first Oxford-Astrazeneca vaccines made their way into people's arms. By mid-march, 11 million people had received the jab.After successive lockdowns, it felt like a way out. But now, more than two years on, storm clouds are gathering.Today, 80 of them are preparing to sue Astrazeneca. They say that until now, no one has wanted to hear their stories. So we're telling them.Find out more: ‘We were told the vaccine was safe - but what happened has been life-changing'Archive used in this episode from: BBC, Sky News, 10 Downing Street.Read more about the Lockdown Files here: www.telegraph.co.uk/news/lockdown-files |For 30 days' free access to The Telegraph: www.telegraph.co.uk/lockdownfilespodcast |If you have any information that could help the investigation, you can email the team on lockdownfiles@telegraph.co.uk | Hosted on Acast. See acast.com/privacy for more information.

歡迎留言告訴我們你對這一集的想法： https://open.firstory.me/user/cl81kivnk00dn01wffhwxdg2s/comments Topic: Traditional Toys May Beat Gadgets in Language Development 嬰兒筆電，嬰兒手機，交談農場，這些都是當前推出快速又先進的玩具，許多被當成激發嬰兒語言技能的工具行銷。 Baby laptops, baby cellphones, talking farms — these are the whirring, whiz-bang toys of the moment, many of them marketed as tools to encourage babies' language skills. 不過，新研究報告質疑這類電子玩具是否會使嬰兒跟父母的口頭交流減少，這種交流對認知發展極其重要。 But a new study raises questions about whether such electronic playthings make it less likely that babies will engage in the verbal give-and-take with their parents that is so crucial to cognitive development. 發表於「美國醫學會小兒科學期刊」的該研究報告發現，嬰兒與父母玩廣告中特別宣傳能促進語言發展的電子玩具時，父母說話及對嬰兒發聲的回應，要比玩傳統玩具如積木或閱讀硬頁書時來得少。嬰兒玩電子玩具時發聲也較少。 The study, published in JAMA Pediatrics, found that when babies and parents played with electronic toys that are specifically advertised as language-promoters, parents spoke less and responded less to baby babbling than when they played with traditional toys like blocks or read board books. Babies also vocalized less when playing with electronic toys. 帶領研究的弗拉格斯塔夫北亞利桑納大學傳播科學與溝通障礙副教授安娜．索沙說：「我的直覺是，他們讓嬰兒跟玩具互動，自己退居一邊。」 "My hunch is that they were letting the baby interact with the toy and they were on the sidelines," said Anna V. Sosa, an associate professor of communications science and disorders at Northern Arizona University in Flagstaff, who led the study. 這項研究建立在日漸增多的一些研究結果之上，既有結果顯示電子玩具和電子書可能使父母較少與小孩進行最有意義類型的口語交流。 天普大學心理學教授凱西．赫許帕塞克說：「當使用這類工具與裝置時，父母們就會閉口。你做的是更多行為規範，像是『別碰那』或『做這個』，甚至啥也不做，因為電子書與玩具已代勞了。」赫許帕塞克未參加上述研究，但此前對電子書跟電子形狀分類盒的研究有類似發現。 The study builds on a growing body of research suggesting that electronic toys and e-books can make parents less likely to have the most meaningful kinds of verbal exchanges with their children. "When you put the gadgets and gizmos in, the parents stop talking," said Kathy Hirsh-Pasek, a professor of psychology at Temple University who was not involved in the new study, but who has found similar effects with e-books and electronic shape-sorters. "What you get is more behavioral regulation stuff, like 'don't touch that' or 'do this,' or nothing because the books and toys take it over for you." 她並補充道：「玩玩具應是玩具只占10%，90％由小孩做主，許多這些電子玩具卻是玩具占了90%以上，小孩只能補白。」 索沙說，她對結果感到驚訝。她原本預期一些父母嬰兒組玩某種玩具時說話較多，而其他組則是在玩另種玩具時說較多話。 She added, "A toy should be 10 percent toy and 90 percent child, and with a lot of these electronic toys the toy takes over 90 percent and the child just fills in the blank." Sosa said she was surprised by the results. She had expected some parent-baby pairs would talk more with one type of toy, while others would talk more with another. 然而，結果卻幾乎一致。玩電子玩具時父母平均每分鐘說40字，少於玩傳統玩具的56字，及讀書時的67字。 But the results were consistent almost across the board. When electronic toys were being used, parents said about 40 words per minute, on average, compared with 56 words per minute for traditional toys and 67 words per minute with books. 這是個小型研究，共26個家庭參與，多為受過良好教育的白人家庭。因此研究人員說，若以更大、更多樣化的群體為研究對象，結果可能不同，但這個研究仍值得注意，因為它盡力捕捉現實世界中無研究人員觀看下的居家親子遊戲時間。 The study was small — 26 families — and most were white and educated. So the researchers say the results might be different with a larger and more diverse group. But the study is notable because it sought to capture real world parent-child playtime in their homes without researchers watching. Source article: https://paper.udn.com/udnpaper/POH0067/292769/web/ Next Article Topic: Boffin Barbie- toy creator honors vaccine co-creator Toy giant Mattel said Wednesday last week it hoped to “inspire the next generation” after creating a model of its iconic Barbie doll in honor of Sarah Gilbert, co-creator of the Oxford/AstraZeneca coronavirus vaccine. 玩具大廠美泰兒公司上週三表示，為表彰牛津／阿斯捷利康冠狀病毒疫苗之共同發明人莎拉‧吉伯特，該公司為其著名產品芭比娃娃開發了新款，希望能「鼓舞下一代」。 Gilbert said she found the news “very strange” but hoped “children who see my Barbie will realize how vital careers in science are to help the world around us.” 吉伯特聽聞此消息，說她覺得「挺怪的」，但希望「看到我的芭比娃娃的孩子們會了解，科學職業對幫助我們周遭的世界是多麼重要」。 “My wish is that my doll will show children careers they may not be aware of, like a vaccinologist.” The toy company created models in honor of five other women in the sciences: US healthcare workers Amy O'Sullivan and Audrey Cruz, Canadian campaigner Chika Stacy Oriuwa, Brazilian researcher Jaqueline Goes de Jesus and Australian medic Kirby White. 「希望我的玩偶會向孩子們展示他們可能不知道的職業，比如說疫苗學家」。 這家玩具公司也設計了其他款式，來表彰五位科學界的女性：美國醫護人員艾米‧奧沙利文及奧黛莉‧克魯茲、加拿大活動人士奇卡‧史岱西‧奧里瓦、巴西研究人員賈克琳‧戈耶思‧德‧杰索斯，以及澳洲醫師克兒比‧懷特。 “Barbie recognizes that all frontline workers have made tremendous sacrifices when confronting the pandemic and the challenges it heightened,” said Lisa McKnight, senior vice president of Barbie and dolls at Mattel. 美泰兒公司芭比娃娃及玩偶部門高級副總裁麗莎‧麥克奈特表示：「芭比肯定所有前線工作人員，在面對疫情大流行及加劇的挑戰時，都做出了巨大犧牲」。 “To shine a light on their efforts, we are sharing their stories and leveraging Barbie's platform to inspire the next generation to take after these heroes and give back.” “Our hope is to nurture and ignite the imaginations of children playing out their own storyline as heroes.” 「為彰顯其努力，我們分享他們的故事，並利用芭比娃娃這平台，來激勵下一代追隨這些英雄並做出回饋」。「我們希望培養及點燃孩子的想像力，讓他們在遊戲扮演角色時，有自己的英雄故事」。Source article: https://www.taipeitimes.com/News/lang/archives/2021/08/09/2003762257 Next Article Topic: Giant Japanese robot spurs hopes for tourism after virus hit 受病毒衝擊後 巨大的日本機器人為觀光業燃起希望 An 18-metre “Gundam” robot that can walk and move its arms was unveiled in Japan on Monday amid hopes that it will help invigorate tourism hit by COVID-19. 一個18公尺、可以走動及移動手臂的「鋼彈」機器人週一在日本亮相，希望它能幫忙振興受到2019冠狀病毒疾病衝擊的觀光業。 The robot is modelled after a figure in “Mobile Suit Gundam”, a Japanese cartoon first launched in the late 1970s about enormous battle robots piloted by humans. The series spawned multiple spin-offs and toys and gained a worldwide following. 這個機器人仿照「機動戰士鋼彈」其中一款打造，這部日本卡通於1970年代晚期首度發表，描述了由人類操控之大型戰鬥機器人。一系列漫畫催生出多項衍生產品與玩具，並獲得全球關注。 It will be the centrepiece of the Gundam Factory Yokohama, a tourist attraction that opens on Dec. 19 in the port city. 它將是12月19日於橫濱這個港市開張的觀光景點「橫濱鋼彈工廠」最引人入勝的核心。 “I hope this will lead to stimulating tourism demand and revitalising local areas,” Chief Cabinet Secretary Katsunobu Kato told a news conference. 內閣官房長官加藤勝信在記者會說，「我希望這會帶動刺激觀光需求並振興當地。」 Source article: https://features.ltn.com.tw/english/article/paper/1417730 Powered by Firstory Hosting

Sarah Gilbert is the Said Professor of Vaccinology at the University of Oxford. She works on vaccines for many different emerging pathogens, including influenza, Nipah, MERS, Lassa, Crimean-Congo haemorrhagic fever, and in 2020, she initiated the SARS-CoV-2 vaccine project. Working with Oxford colleagues she is able to take novel vaccines from design to clinical development, with a particular interest in the rapid transfer of vaccines into manufacturing and first in human trials. She is the Oxford Project Leader for ChAdOx1 nCoV-19, a vaccine against the novel coronavirus, SARS-CoV-2 which is now in use in many countries around the world. Read more in her book Vaxxers: A Pioneering Movement in Scientific History

Episode ini menambah daftar panjang ilmuwan anak bangsa yang berperan penting dalam peradaban. Dalam darah sebagian manusia hari ini, mengalir hasil karya Dr. Carina Citra Dewi Joe, Ph.D., pemegang hak paten vaksin Oxford-AstraZeneca. Carina membagikan kisah perjuangannya dalam mengakselerasi pengembangan vaksin tersebut selama satu setengah tahun, yang berhasil menuntunnya mendapatkan penghargaan Pride of Britain. Namun, COVID-19 belum usai. Masa depan juga masih menyimpan tanda tanya pandemi lain yang bisa kapan saja datang. Karena itu, Carina menegaskan pentingnya dunia untuk memetik pelajaran berharga dari pengalaman ini agar siap dalam menghadapi dan menyikapi tantangan pandemi selanjutnya. Carina juga memberikan pandangannya mengenai ketimpangan gender di saintek. Baginya, keberanian adalah akar dari kemajuan—termasuk inovasi vaksin Oxford-AstraZeneca yang tidak mungkin lahir dari nihilnya keberanian Carina dalam mengemukakan dan mempertahankan pemikirannya. #Endgame #GitaWirjawan #CarinaJoe ------------------------ Magister Kebijakan Publik SGPP Indonesia Pendaftaran Maret 2023 admissions.sgpp.ac.id admissions@sgpp.ac.id https://wa.me/628111522504 Playlist episode "Endgame" lainnya: https://endgame.id/wanderingscientists https://endgame.id/thetake https://endgame.id/spirituality Kunjungi dan subscribe: @SGPPIndonesia @VisinemaPictures

When the world was brought to a halt by the COVID-19 pandemic, individuals all over the world stepped up to the job of saving lives and ‘bringing normal back again'. In Oxford, Dr Adam Ritchie was one of them. In this episode of OxPods, Miya McFarlane, Human Sciences undergraduate at Regents Park College, interviews Dr Ritchie, a senior programme manager of the Oxford-AstraZeneca mass vaccine program, on how he helped vaccinate people all over world.

Kiwi born renown immunologist Michelle Lintermann, talks about her research into how our immune system changes as we age. Dr Lintermann is a New Zealand born immunologist works at the Babraham Institute at the University of Cambridge, where she leads a research group and lab facilities for testing responses to new vaccines. Her research programme focuses on how the immune system mounts a good response against vaccination, and why vaccines don't always work as well for certain age groups. Early in the Covid pandemic, her team ran an important preclinical study of the Oxford AstraZeneca vaccine in aged mice, in order to test how that vaccine would act in older bodies. Dr Lintermann is in New Zealand at the moment, based at the Malaghan Institute.

More than a million people in the United States have been killed by COVID-19 in the past 3 years. The numbers would be much higher, but the vaccines were developed with amazing speed. Time and again, the vaccines have been shown to be safe and effective. Yet some people persist in claiming the mRNA vaccines are causing an epidemic of stroke. The data is clear. They do not. If you want to reduce your chances of stroke, get the vaccine. The new thing that causes stroke over the past few years is COVID-19 itself. If you want to decrease your chances of having a stroke (or another stroke) don't get a severe COVID-19 infection. And the simplest thing you can do to reduce your chances of getting a severe COVID-19 infection is to get the COVID-19 vaccine. If you do catch COVID-19 despite the vaccine, the data shows it will be much less severe and much less likely to be fatal.  In addition to protecting yourself, you are also helping to protect others who may not be medically eligible to get the vaccine. The COVID-19 mRNA vaccines are saving lives every day. In this episode ... In this episode, I talk with data scientist and epidemiologist Dr. Remle Crowe about the research studies coming out now that show what we already knew from earlier research: the COVID-19 vaccine does not increase your risk stroke. We talk about several studies, and we talk about how you can do your own research on the credibility of these studies and evaluate how well they reflect the scientific reality of our world. In this post, you'll also find links to a bunch of these studies that you can read for yourself. Start by listening to this conversation. If you don't seed the audio player below visit http://Strokecast.com/MSN/vaccine to listen to the whole conversation.   Click here for a machine-generated transcript   I got my Bivalent COVID-19 booster and my 2022 Flu shot on the same day in October. Who is Dr. Remle Crowe? Dr. Remle Crowe is an expert in EMS research and quality improvement. From truck clutches to clinical care, she has shown how research and improvement science work to solve problems across fields. Prior to earning a PhD in Epidemiology, her EMS career began with the Red Cross in Mexico City as a volunteer EMT. She has authored numerous peer-reviewed publications related to prehospital care and the EMS workforce. Now, as a research scientist with ESO, Dr. Crowe routinely uses EMS data to improve community health and safety. Dr. Crowe previously appeared on the Strokecast in episode 132 to discuss the AHORA pneumonic to help Spanish speakers recognize and respond to a stroke. When it comes to stroke, Time is Brain regardless of which language you speak. A Sampling of the Studies When we claim the data indicates that the vaccine doesn't cause an increase in stroke, what data are we talking about? How did "they" analyze it? Who reviewed the studies to ensure they were accurate? Where can you read the details yourself? As Dr. Crowe explained, there are currently a whole bunch of studies that are coming out. That makes sense; it's roughly 18 months since the vaccines against COVID-19 became widely available. To conduct sound research, you need a large pool of people to look at. You need to take some time to see the results. You need to write up those results. Then you need to submit them for publication. Publications will then need to review before publishing them. That brings us to where we are today with all these studies now becoming available. Let's take a look at a few of them, and I encourage you to click through to the details and read them yourself. Click the study titles for more. Surveillance for Adverse Events After COVID-19 mRNA Vaccination This study published in JAMA (Journal of the American Medical Association) looked at nearly 12 million doses of the mRNA vaccine given to more than 6 million people. This is what they learned: "The incidence of events per 1 000 000 person-years during the risk vs comparison intervals for ischemic stroke was 1612 vs 1781 " In other words, the time period at greatest risk for stroke did not see an increased risk. They concluded: "In interim analyses of surveillance of mRNA COVID-19 vaccines, incidence of selected serious outcomes was not significantly higher 1 to 21 days postvaccination compared with 22 to 42 days postvaccination. While CIs were wide for many outcomes, surveillance is ongoing." COVID-19 Incidence and Death Rates Among Unvaccinated and Fully Vaccinated Adults with and Without Booster Doses During Periods of Delta and Omicron Variant Emergence — 25 U.S. Jurisdictions, April 4–December 25, 2021 We talked about this report from the CDC Morbidity and Mortality Weekly Report during the episode. This study looked at infections and deaths among vaccinated folks and unvaccinated folks. The rate of infection and death from COVID-19 was much higher among unvaccinated folks than among vaccinated or vaccinated and boosted folks. The report says: "Rates of COVID-19 cases were lowest among fully vaccinated persons with a booster dose, compared with fully vaccinated persons without a booster dose, and much lower than rates among unvaccinated persons during October–November (25.0, 87.7, and 347.8 per 100,000 population, respectively) and December 2021 (148.6, 254.8, and 725.6 per 100,000 population, respectively) (Table 2). Similar trends were noted for differences in the mortality rates among these three groups (0.1, 0.6, and 7.8 per 100,000 population, respectively) during October–November." Even though the vaccine does not guarantee a person will avoid COVID-19, it greatly increases their chances of avoiding infection. And if they do become infected, the vaccine greatly increases their chances of survival. Acute ischemic stroke and vaccine-induced immune thrombotic thrombocytopenia post COVID-19 vaccination; a systematic review This study in the Journal of Neurological Sciences looked throughout the published literature and found just 43 incidents of stroke following the vaccine administration. "AIS has been reported as a rare complication within 4 weeks post COVID-19 vaccination, particularly with viral vector vaccines. Health care providers should be familiar with this rare consequence of COVID-19 vaccination in particular in the context of VITT to make a timely diagnosis and appropriate treatment plan." The report specifically called out the risk of “viral vector vaccines” (and, again, it's a shockingly small risk). The most common viral vector COVID-19 vaccines are those from Johnson & Johnson and from Oxford-AstraZeneca. The mRNA vaccines from Moderna and Pfizer are not viral vector vaccines., indicating that those appear to be even safer. The recommendation is not to avoid vaccination. It's an extremely rare complication. The recommendation is to watch for signs of stroke, which is something we should be doing all the time anyway. Association Between Vaccination and Acute Myocardial Infarction and Ischemic Stroke After COVID-19 Infection This article, published in JAMA looked at what happens after a COVID-19 infection for both vaccinated and unvaccinated folks. If someone does get infected and, does their vaccination status reduce the impacts of infection? Yes, it does. In fact, folks who got the vaccine and the got COVID were LESS likely to have a stroke or heart attack after their COVID infection. "This study found that full vaccination against COVID-19 was associated with a reduced risk of AMI [heart attack] and ischemic stroke after COVID-19. The findings support vaccination, especially for those with risk factors for cardiovascular diseases." Risk of thrombocytopenia and thromboembolism after covid-19 vaccination and SARS-CoV-2 positive testing: self-controlled case series study This study in the UK looked at patients who had been infected with COVID-19 or who had received the vaccine. More than 30 million people were part of the study. The conclusions were clear: "Increased risks of haematological and vascular events that led to hospital admission or death were observed for short time intervals after first doses of the ChAdOx1 nCoV-19 and BNT162b2 mRNA vaccines. The risks of most of these events were substantially higher and more prolonged after SARS-CoV-2 infection than after vaccination in the same population." Even if there is a slight risk from vaccination, the risk from the actual disease is much higher. COVID-19 vaccine not linked to increased risk of stroke Not all research becomes available without a subscription. Researchers at Cedars-Sinai have found similar results to other studies though and have come to the same conclusion. "Newly compiled data evaluated by researchers in the Department of Neurology and the Smidt Heart Institute at Cedars-Sinai shows that COVID-19 vaccines do not raise stroke risk--but that severe COVID-19 infection does. Physician-scientists hope this growing body of evidence, highlighted today in an editorial in the peer-reviewed journal Neurology, will ease the minds of individuals still hesitant to be vaccinated." Risk of Myocarditis After Sequential Doses of COVID-19 Vaccine and SARS-CoV-2 Infection by Age and Sex We talked about this study in the conversation with Dr. Crowe. At first glance it is concerning. This is the conclusion: "Overall, the risk of myocarditis is greater after SARS-CoV-2 infection than after COVID-19 vaccination and remains modest after sequential doses including a booster dose of BNT162b2 mRNA vaccine. However, the risk of myocarditis after vaccination is higher in younger men, particularly after a second dose of the mRNA-1273 vaccine." That does seem scary for young men, and there are a couple things to keep in mind. First, the number of events was so small that it's tough to draw firm conclusions. When you get down to such low numbers, that stats can do weird things. Second, this was based on the adverse event reporting system. That does not prove causality. It just flags something to look at more closely if there are large numbers. Which there are not. The point of all this research, though, is to learn more and compile more and more evidence. And ultimately to let the body of evidence guide decision making and recommendations. What we know at this point is that the risk of stroke after a COVID-19 infection is much higher than the risk of stroke following a vaccination. And the risk of stroke after COVID-19 infection is much lower in folks that have been vaccinated than it is in those who have not been vaccinated. COVID-19 is not gone. It is still out there in the world infecting people, killing people, and giving people strokes. Billions of vaccinations later, this is what the data tells us. The simplest way to reduce your risk of stroke is to get the vaccine and stay boosted. Do Your Own Research We talked about a bunch of research in the podcast, and we looked at a bunch of reports above. You don't have to just accept my commentary or Dr. Crowe's. You can read the reports yourself and look at the data and see why the vast majority of medical professionals have concluded the vaccines are safe and effective. Dr. Crowe offered a number of tips to help you do your research. You'll find them and more in this list. Tip 1 Search research focused search engines and directories to find studies and resources. Google Scholar and PubMed are great places to start. Tip 2 Look at the Publication that publishes the research. Is it well known for scientific rigor? Does it have a strong requirement for peer review of articles? Or can someone publish in it by simply paying a fee? Tip 3 Search for the publication's Impact Factor. The more other publications that cite its work, the higher the number. A publication with a higher impact factor is likely more credible. Tip 4 When you get to the actual study, look at what type it is. If it was a case study, that's interesting. If it was a randomized, double-blind, placebo-controlled study on a large scale, that's even better. If it was a systemic review evaluating hundreds of other studies, that's stronger still. Tip 5 Look at how many people were part of the study. A few dozen is interesting. A few million is much more likely to yield credible results. Tip 6 Look at the results of the study, relative to the size of the study. A few results out of a dozen is one thing. A few results out of millions of subjects is another matter altogether. Tip 7 Look at the goal of the study. What were the authors hoping to demonstrate? Did they succeed? Why or why not? Tip 8 Consider confounding. Studies generally deal with a subset of the population -- a limited number of people -- and seek to extrapolate those results and draw conclusions about the broader population.  For those conclusions to be valid, though, the group studied needs to be similar to the group the study extrapolates to. The more different the groups are, the less reliable the results. Tip 9 Finally, does the study demonstrate causality or just coincidence? There's a reason folks will often say, “Correlation does not equal causation.” For example, the FDA Adverse Event Reporting System (FAERS) Public Dashboard is a collection of negative things that happen to a person after they get a vaccine. It's not a list of events caused by the vaccine. If a person gets hit by a bus after getting the vaccine, that can go in the database. It's an adverse event. That doesn't mean the vaccine caused the bus accident. Read the study carefully to see if the authors claim a causal relationship and if that relationship is supported by the evidence in the study. AHORA The last time Dr. Crowe was on the show was to talk about the AHORA messaging to help Spanish speakers recognize and respond to stroke. It's basically the equivalent of the BEFAST messaging we talk about a lot in English. Here is the stroke warning pneumonic device in Spanish. Download it and share it far and wide. Reconocer los signos de un accidente cerebrovascular y responder rápidamente. ¡Llame a una ambulancia si observa estas señales! Let's look at a translation. Letter Abbreviation for Spanish Description In English A Andar Tiene dificultad para andar? Tiene problemas con el equilibrio? Do they have difficulty walking? Do they have problems with balance? H Hablar Tiene dificultad para hablar o entender? Usa palabras que no tienen sentido? Do they have difficulty speaking or understanding language? Do they use words that don't make sense? O Ojos Tiene algün cambio de vista? Tiene visiön doble? Tiene dificultad para ver con ambos ojos? Do they have some change in vision? Do the have double vision? Do they have difficulty seeing with both eyes? R Rostro Tiene la mitad del rostro caido? Tiene un repentino dolor de cabeza como nunca se ha sentido? Do they have one-sided facial droop? Do they suddenly have the worst headache of their life? A Ambos Brazos Tiene dificultad para levantar un brazo o una pierna? Tiene debilidad en un brazo o una pierna? Do they have difficulty lifting an arm or a leg? Do they have weakness in an rm or a leg? And, of course, here is the BE FAST messaging for English speakers. Recognize the signs of a stroke and respond quickly. Call an ambulance if you observe these signs! Both sets of symptoms look for the same thing. The AHORA messaging includes legs and headaches. The BE FAST messaging specifically calls out calling an ambulance. Regardless, the more people that can recognize a stroke as it is happening, the better off we will all be. Pop Culture Moment During the conversation, Remle mentioned she is a big fan of the movie Sliding Doors. It's an examination of how simple moment can change the course of your life. What path lies ahead if we catch that train or miss it? https://www.youtube.com/watch?v=Da-Mizk86AE&ab_channel=Shout%21Factory Or what happens if we turn right instead of turning left? https://www.youtube.com/watch?v=YnzbuU5I7RI&ab_channel=DoctorWho In reflecting on the past, it's easy to get fixated on thing were so much better back then, but it's never that simple, is it? Billy Joel reminds us that: "The good old days weren't always good, and tomorrow ain't as bad as it seems." https://www.youtube.com/watch?v=ph7oZnBH05s&ab_channel=billyjoelVEVO Other Shows Journal Club Remle mentioned her show, PCRF Journal Club, which is a journal review webinar that meets each month. They go deep into looking at the latest research studies that are coming out. The focus is on research around EMS -- the ambulance and transport industry. If you'd like to learn more, check out its site here: https://www.cpc.mednet.ucla.edu/pcrf Successful and Disabled I was also recently featured on another podcast focused on being successful as a person with disabilities. I joined host Christ Mitchell on the Successful and Disabled podcast to share my story and discuss how I use mindset to drive my recovery and other goals in life. Listen to it here. If you don't see the audio player below, visit http://Strokecast.com/MSN/Vaccine to listen to the conversation: Hack of the Week Reading a paper book can be challenging with one functional hand. It's even harder if you try to do that while eating a meal. Why? Because books don't always want to stay open on their own. You have to hold them open, which makes it harder to pick up your cheeseburger. I use my phone to address this problem. I open the book and then lay my phone across the open pages. It's just heavy enough to keep the book from snapping shut so I can enjoy feeding my belly as I also enjoy feeding my mind. Give it a try. Links  Where do we go from here? Check out the links above to learn more about why getting the vaccine is safer than not getting the vaccine Share this episode with someone you know by giving them the link http://Strokecast.com/vaccine Do you have a recent win or victory in your recovery? Share it by calling 321-5 STROKE Get your vaccine and booster to protect against COVID if your doctor advises it Don't get best…get better

The UK was the first country in the world to begin its formal vaccine rollout, starting with the 91 year old Margaret Keenan. In the years since, the pandemic has been almost entirely routed in this country (though its impact on the economy, on healthcare, on the criminal justice system, continue to be suffered). But the British vaccine – developed by Oxford University and AstraZeneca – was a key part of the global fight against the pandemic. What was it like to be on the inside during those crucial first months? The Spectator has brought together politicians, advisors and scientists who played key roles during that time, to reveal a picture of dealing with unprecedented crisis in smart ways. On this episode: Kate Andrews, The Spectator's economics editor, talks to Nadhim Zahawi (Chancellor of the Duchy of Lancaster who had been the first Vaccines Minister during the pandemic); Jamie Njoku-Goodwin, head of UK Music who was a special advisor to then-Health Secretary Matt Hancock; Professor Andrew Pollard, chief investigator for the clinical trials of the Oxford-AstraZeneca vaccine; and Isabel Hardman, The Spectator's assistant editor. This episode is the first of a mini-series taking a look at Britain in the world, sponsored by the Bill and Melinda Gates Foundation.

First of all, I think your superpower is just making things really easy. You already know the blueprint, the strategy, you've got everything there and you just fed that to me in a way that I was easily able to make my book a success.Doone Roisin is the creator and host of Female Startup Club, a Top Ten Entrepreneurship Podcast and the bestselling author of Your Hype Girl: 51 Female Founders Share Their Most Impactful Learnings, Tactics & Strategies In Business.I advised Doone in the lead-up to her book launch in March of this year and she has since connected me with several clients. As a result of these experiences I have started a book consulting business: Ben Guest Book Consulting. On my website are the services I offer, my rates, and testimonials, including this from Doone:I worked with Ben ahead of self-publishing my debut book. He helped me with publishing, marketing and promotion. My book, Your Hype Girl, hit #1 in multiple categories on Amazon including "Women & Business", "Ecommerce and Small Business", as well as hitting the top 100 of all paperback books in my home country of Australia (#55). I did everything Ben taught me and the results were so much more than I had anticipated. We smashed every goal that was set and more. I can't recommend Ben enough!Everyone has a story to tell. When you're ready to tell your story please reach out.In 2022, Doone was named Australian Young Achiever of the Year in the UK and, as a result, met Prince Charles at Buckingham Palace. In this conversation, Doone and I talk:The ancillary benefits of publishing a bookHolding a physical copy of your book for the first timeTrends Group on FacebookUsing TikTok to promote your bookThe power of organic word-of-mouthWhy having a checklist is keyIdentifying your “comparable” author and bookBen Guest Book Consultant. Rates here.Meeting Prince CharlesVIDEOTRANSCRIPTBen Guest (00:02):Hi, everyone. This is Ben Guest, and today's conversation is with Doone Roisin. Doone is the creator and host of the podcast Female Startup Club, which is a top 10 podcast in the entrepreneurship category. And I helped Doone with the final stages of publishing and then marketing and promoting her book, Your Hype Girl, which she released in March, and hit number one in a bunch of categories, was the number 55 overall bestselling paperback book in Australia. Doone is Australian, but currently lives in England, and ended up with her being invited to Buckingham Palace to meet Prince Charles.Ben Guest (00:46):So in this interview, we talk about all the steps we took to promote her book and the actionable items to make it a number one best seller in multiple categories. And also, kind of as an outgrowth of that project, a few other people have contacted me about helping them with their book launch or even other aspects of writing and editing their book. And so, I'm now launching a book consulting business, and you can find that at benguest.net, where I have all the services I offer, testimonials, my rates, et cetera. And essentially, Doone was my first client. So enjoy our conversation.Ben Guest (01:29):Doone, great to see you.Doone Roisin (01:31):It's good to see you too, Ben.Ben Guest (01:33):So, Your Hype Girl has been out in the world. How successful was your launch?Doone Roisin (01:39):Oh my gosh. It has been out in the world since, when did we launch it? March? It's been a while. March, April, May, June, July, August, five months. Wow, that's crazy. So how did it go? I would say it was pretty damn successful. For me personally, I wanted that offline experience to give to my audience, give to my community, and have that kind of thing that's out there physical that I could ship to people and hold. And so, for me success was literally just number one, getting that out in the world and having that there, so obviously, tick.Doone Roisin (02:15):I also was thinking about what success was to me, in terms of I wanted to hit the best seller list on Amazon for the categories that I really cared about. And the categories that I really cared about were women in business, eCommerce, maybe small business or something like that. They were the ones that I cared about, but I was also like, "We'll see," because I obviously had no benchmark against what I had done before because it was totally new to me.Doone Roisin (02:48):Yeah. It went better than expected. I hit all the bestseller categories that I wanted to and so many others. I hit them, I think, day of for some of them. I hit women in business day of, and I had estimated based on our talking, that could take three months maybe, chipping away, so I was really stoked with that.Doone Roisin (03:08):And I think the things that I didn't expect to come from it were the success in terms of speaking opportunities and the opportunities that came out of having the book out in the world. So last week I spoke to the women at JP Morgan about my journey and the book and entrepreneurship in general. I landed a gig sitting on an investment committee to be part of this new fund that's launching in Australia, which is going to be funding women-founded tech companies that are in impact and purpose-driven sectors. And so, that has just been so wild.Doone Roisin (03:47):It also led to, I won Young Australian Achiever of the Year from the High Commissioner of Australia, which led to me going to Buckingham Palace and meeting the future king of England. All these things rattled off the back end of the book which I hadn't put in my goals to begin with, but it really was like, "Whoa." When I take a step back now and I look at that, I'm like, "Damn that's cool."Ben Guest (04:13):It's amazing.Doone Roisin (04:14):Yeah. Yeah. It's been really cool. And I think the other thing that I probably expected to happen but didn't realize how amazing it is, which I should know because I already get a thrill from getting DMs from my community in general, but still seeing the power of the book out in the world. So people sending me a message of how it's impacted them, why they're loving it, sharing about it on social media, that feeling is just priceless. It's so cool. So yeah, those are the kind of goals that I had. I wasn't looking at it as a revenue driver for me, which I think is a really hard goal to have if you are going to be an author, especially first time. But yeah, that wasn't a goal for me.Ben Guest (04:59):So much of what we do is in the digital world, podcasts and Zoom meetings and social media and so forth. But one of the first things you mentioned was having the physical book in your hand. Can you talk about the first time you held it, leafing through it, what the difference between something you're working on digitally and having a physical copy in your hands?Doone Roisin (05:20):Oh my gosh. I recorded the moment that I opened the final copy. And I have my dog on my lap, and it's this video where I'm just so happy and bubbling over with emotion because I was like, "Wow, I actually did this. I made this book. And this book is now out in the world, impacting thousands of other women, thousands of other business owners, future business owners. How cool is that?"Ben Guest (05:46):So we connected through the Trends group on Facebook. And I think you had pretty much had the manuscript finished. I had just published my book, and I had written up sort of a list of, "Okay, here's what worked well for me in terms of publishing and marketing." And then we connected, and so I helped guide you through that, the marketing and promotion phase, publishing, marketing, promotion. And then, of course, that led to a whole bunch of more opportunities. And now I'm launching my book consulting business, but it all started from you and I connecting on Trends group. And you mentioned-Doone Roisin (06:24):Shout out to Trends.Ben Guest (06:25):Shout out the Trends.Doone Roisin (06:25):I love Trends.Ben Guest (06:27):So many great opportunities and people on that group. And you mentioned that your book hit multiple best seller categories on Amazon, but let's not undersell it. You hit number one. And the number one category that we talked about, I think the first time we talked, was women in business. That was the category. That was the goal. Okay, this is a big category. It's tied directly to what your book is about and what your life is about. And not only did you hit the bestseller list, you hit number one.Doone Roisin (06:57):Yeah, it was pretty cool. We also hit, maybe a week later or maybe a few days later, we hit top 55 of all paperback books in Australia. And I was like, "What? This is wild." But yeah, it's crazy. And I think for me, we started the marketing plan two months out or maybe three months out, and would say that was a fine amount of time. Maybe three months is the optimal and two months is the absolute minimum. Somewhere in there is the sweet spot in terms of putting a lot of your energy and effort into drumming up the interest, drumming up Your Hype Girls who are going to support you and cheerlead and shout for you. Yeah. Amazing. I can't believe that I hit number one in all those categories, so wild.Ben Guest (07:49):So let's break it down. In terms of marketing, what were the best strategies that you implemented?Doone Roisin (07:55):I would say there's three things that I did really well. One is harder for the everyday person to achieve, and that's obviously because I have an inbuilt community, so I have a podcast, I have social channels, things like that. And I was pumping that message there. My audience was aware of the book coming out for so long. And then, in the lead up, it was every single episode, dropping it in wherever I could. And so, I already knew that people were really excited from my audience.Doone Roisin (08:25):But besides that kind of piece of the puzzle, the two other main things that really made a difference and shifted the needle was TikTok and hand-to-hand combat, and I'll break down both of those. When it came to TikTok, my approach was for the three months leading up, I doubled down on content creation organically. So I was posting three times a day. I was talking about the book. I was talking about Female Startup Club. I was just pushing out that content. And it's a lot, even three videos is a lot per day, and we grew a lot in that time as well. So when the book came out, there was again, more of an audience who were ready to buy and ready to be excited and ready to get involved.Doone Roisin (09:13):And again, it's one of those things. I think people often lean straight towards paid marketing or kind of this magic pill that actually, it's not the money you need to invest, it's the time you need to invest to create valuable content that's exciting and gets people excited authentically about what you're doing. And so, TikTok for me on the organic side was really important. I was creating a lot of content and then I also partnered with a lot of TikTok, or not even a lot, I think it was like 10 influencers ranging from micro-influencers, 1,000, 2,000, 3000 followers, then some medium to large size, a few hundred thousand followers, right up to one TikTok person who had about 3 million followers.Doone Roisin (09:58):And so, that all came out on launch day along with everyone that we were rallying on TikTok and all of our content as well. And I think it just created a really happy buzz on TikTok. And looking back, I tried a number of different things. I tried PR that didn't work for me. I wasted a lot of time pedaling. It didn't come to fruition. I got a few good things. I got a feature in Refinery, which was absolutely amazing, but I pedaled a lot to get not a lot of return.Doone Roisin (10:30):And TikTok was one of those things where looking back, it's hard to see, obviously with Amazon, you're not able to own your customer data. You're not able to see the traffic, where it's coming from, all that kind of stuff. But anecdotally, I could see people in the comments on the videos of the influencers that were posting, being like, "Just ordered my copy." So I was able to see that real time feedback from people who were supporters.Doone Roisin (10:56):And then the second thing that worked really well for me again, which was a time investment versus a money investment, was just hand-to-hand combat. And so, what I did was I went through absolutely every single thing that I could to make a list. I made this huge spreadsheet of everything. I went through my entire emails, and went through and found every single person I knew that had a newsletter who could be a potential newsletter to spread the word. Any kind of email-focused community, I wrote that on a list.Doone Roisin (11:31):I went through everyone in my Facebook friends. Who do I know and hear that could either shout about it, could introduce me to someone who has a community of their own on Facebook, put that on the list. I also did this for Facebook groups. What Facebook groups am I a part of? Can I reach out to the admin owner? Can I ask them if I can provide some value, give a talk, provide some resources in return for promotion about the book? I went through every single WhatsApp conversation and I listed out all of my friends who were going to be happy to shout about me on social media, all my friends of friends. I asked them if they would tell their friends. I think on the day I had a group of my core best friends in a WhatsApp group, and I asked them to send it to five people that they thought would love the book. And so, everyone was becoming my hype girl.Doone Roisin (12:18):I also made lists of podcasters that I knew. I tried to think about, "Who do I know, even if it's really far disconnected and not my direct community, who has a community that I could call in that favor?" And this is why networking and relationship building is so important, because the day that you have something that you need to have people rallying for you, you're able to knock on that door and be like, "Hey, today's the day. I need some help. Can you help me?" And yeah, I just went through everything, LinkedIn, Instagram. I just made tons of lists, and then I just had a column where it was their name, how I'm going to reach out to them and on what channel, and have I reached out to them, and then the follow up.Doone Roisin (13:01):And I just started sending messages, obviously super personalized, literally one-to-one, "Here's what I'm doing. Here's how I'd love to see if you could help me." Whether it was through a paid shout out or whether it was through just organic, whatever it might be, but figuring out, depending on the relationship, what made sense. And that seriously was what I attribute a lot of the success to, because I just did one by one. I was not going for a mass approach with things like paid ads where you're just spraying money at a wall and seeing what sticks and trying to find that audience. I was going to directly audiences that I already knew and just telling them what I was up to and seeing if there was something that we could do together.Ben Guest (13:48):One of the things that both you and I didn't do was paid advertising on Amazon ads, Facebook ads, et cetera. You and I, we focused on organic, authentic word of mouth. That's the best kind of marketing promotion you can have. And it's so fun talking to you now. So obviously, I know us working together from my side, and I remember sending you after I think our first conversation, I put together a checklist, a spreadsheet checklist that I shared with you on Google Docs.Ben Guest (14:20):And then, just for the listeners, every couple of weeks, I'd check in and see where Doone was on the checklist and what she checked off. And the tabs kept growing, and everything that you're just describing, you had it all laid out on that checklist and you kept adding more tabs. "Okay. These groups I'm going to reach out to. This community, I'm going to reach out to. These people, I'm going to reach out to, these podcasts." And you just had it all laid out on the checklist.Doone Roisin (14:46):When you sent me the checklist, I was like, "Great. This is the beginning of the master checklist and the master kind of plan," because you house everything in one document, and it just becomes your, "Here is what you need to do every single day, chipping away." And I had all of your things to do on that first tab that I was just able to go through and follow and slowly chip away at over the three months or two months or whatever.Doone Roisin (15:11):And then, I had all of the launch party plans, communities, pricing, what I'd spent, everything else, just everything related to the book lived in that one document. And I even did my recap in there as well, where I afterwards went through and put in all the press that we'd received, not that it was a lot, but we received the Refinery article, a few smaller pieces of press and all the TikTok videos and things like that recapped. So I'm always able to just go back and immediately be like, "Oh yeah, that's right. That's exactly what happened."Doone Roisin (15:44):And it's also good for when you are doing your wrap up, not that I did a report for myself, because I absolutely didn't. But when you look back at all the different initiatives you did, unless you have everything clearly mapped out and in one place, it's pretty easy to forget what you did. And even before this call, I just opened up the document to be like, "Yeah, what did I do? That was five months ago. I forget." So yeah, that checklist was... I love the checklist. It makes life very easy when you have a great checklist that's created from an expert.Ben Guest (16:12):And the cool thing about it is, now that you have that checklist, now you have a plan for the next book.Doone Roisin (16:17):Oh, a hundred percent, a hundred percent. And exactly, you're right. I added notes to it. I would know next time things that I added in along the way. Yeah, it's mandatory, I would say.Ben Guest (16:29):TikTok is the new thing for selling books, so let's dive into that a little bit.Doone Roisin (16:34):The reality of TikTok is the more time you put into it, the more you get out of it, a hundred percent. So when I was posting three times a day, I was growing really quickly because, of course, I'm on there three times a day, pushing new styles of content, trying new different things, really being there when people open their app all the time, basically, whereas now I only post once a day and I can see that's slowed my growth down.Doone Roisin (16:57):But TikTok has been really instrumental actually, in being a discovery channel for my podcast. So I always ask, if someone leaves a kind message in my Instagram DMs or on email or LinkedIn or in TikTok and says, "Oh my God, I love your show" or "I love your podcast," I always reply, and somewhere in that reply, "How did you find the show?" And actually, a lot of the time it's through organic SEO or podcast recommendations in the apps, but the other way that people often say is TikTok.Ben Guest (17:33):What are your tips for authors using TikTok to raise awareness for their books?Doone Roisin (17:40):What are my tips? So if you're new to TikTok and you haven't got any experience on the platform, and you might be someone who is a little insecure about putting your face on the camera and this new style of creating content and things like that, I totally get it. I definitely felt like that in the beginning. It took me a while to get used to it. So first of all, my tip would be just to consume a lot of content that is around your niche.Doone Roisin (18:07):So if you are writing chick lit, and you have a lot of authors that you look up to, go and see if those authors are on TikTok. Or even if it's not linked to your niche, but go and find people who are authors just in general and look up what they're doing. And you can do that by searching the hashtags. There's lots of book talk, book recs, book recommendation. Often there are lots of trends around different books that are going around at the moment or the way that people display their books on TikTok. So I would do a lot of research.Doone Roisin (18:43):I would then spend some time just creating 30 to 50 drafts and not even putting pressure on yourself to post them, but just to get comfortable, get familiar, and get into the groove of how you feel and look and sound on video. And then, there are so many small little tips that you can do with TikTok. For example, one that I heard recently, and I'm sure this stuff changes all the time, but one that I heard recently is if you're going to start a TikTok account, you should immediately start posting explosively the day that you start your account, not tomorrow, not 10 weeks from now.Doone Roisin (19:27):So for example, when I tell you to do 50 drafts, do that on the dummy account, don't use that as your main account. And then, the day that you're ready to start your account, that's the day that you start posting minimum three times a day and you give yourself a 30-day challenge, and you just go all out. And you've already got your list of content that you have found online.Doone Roisin (19:47):What you can also do is look for viral videos that have already got a proven kind of method to how they look, and try and recreate that video. Take inspiration from it, make it your own, but you can see why things have gone viral and take those kind of learnings from that video when you are consuming and researching.Doone Roisin (20:06):And then I would also say, what you can do on TikTok is you go to the search bar, and if you were to search something really specific, not even something specific, let's say book talk, all the top performing videos will come up at the top. And you can even filter it so that you filter it by most liked in the last three months, and then you'll get the most viral videos related to that.Doone Roisin (20:34):And then you can build a bit of an idea around, "Oh, yeah. I can actually create that kind of content. That would work for me and my style and what I like." Or, "Oh, I can see why that worked. I could take elements of that." And build a bit of a content strategy so that when you are gearing up to launch and you're like, "Yep, I have got the time carved out every single day," or "I'm going to batch record every weekend so that I have my 15 videos or however many it is for the week." And then, just the day that you're ready to start that day, get it all out for 30 days or three months.Ben Guest (21:08):And you mentioned something there that it's so key, not for TikTok, but for any type of marketing and promotion you're doing for a book. And this is something that we talked about the very first time that we had a conversation, which is finding your pilot author, finding your comparable author and your comparable book, and seeing what they're doing, what podcasts they're doing interviews on, what they're doing on their social media, what their cover of their book looks like, so on and so forth.Ben Guest (21:39):And the first time that we talked and I said, "Okay, what is a comparable book? Who is a comparable author to your book, which is Your Hype Girl?" And you referenced the book, How to Build a Goddamn Empire by Ali Kriegsman. And just getting ready for the podcast this morning, I clicked over to Amazon and checked out Your Hype Girl on Amazon. And sure enough, it says "frequently bought together," Your Hype Girl.Doone Roisin (22:06):No way.Ben Guest (22:07):And How to Build a Goddamn Empire by Ali Kriegsman. So you nailed the pilot author comparable of, "I want the same audience as this book and this author." And now Amazon has picked that up, and the algorithm has picked that up, and they're matching the two of your books together.Doone Roisin (22:24):Oh, my God, that's so cool. And why that's cool is I really loved watching Ali bring out her book. And we had her on the show when she launched the book. And so, it's so funny that you say that now, knowing those books have still been managed to be linked somehow. I love that for me. It's cool.Ben Guest (22:44):And it's totally organic.Doone Roisin (22:45):Yep. That's so great.Ben Guest (22:46):That's the thing that we're talking about. And for people listening to this podcast who are in whatever phase of writing, editing, publishing their book, the number one takeaway that I want or we want you to have is, you do not have to do this alone. You're not on your own. People have gone before you and done this, so all you have to do... The number one takeaway is find that comparable author and that comparable book, see what they've done, and you just fit in behind what they're doing. Now, I want to be clear-Doone Roisin (23:20):Yes. Reverse engineer it.Ben Guest (23:21):Yes, exactly.Doone Roisin (23:21):Reverse engineer what are the levers that they have pulled that get them in front of audiences that are relevant to that book and how can you repeat it.Ben Guest (23:33):Exactly. And so, I want to be clear, let's say you're writing a book in the horror genre. You don't say, "Okay, my comparable author is Steven King." Right? You don't pick the number one best selling author in your genre. You pick someone that's more closely comparable.Ben Guest (23:46):So the example I always use is right now, I'm finishing up a book project with a retired NBA player, Scott Williams. He played on the Chicago Bulls of the nineties, won three championships, so on and so forth. And he played the position of power forward. So when we're looking at comparable authors, there's another power forward from the nineties, a guy named Charles Oakley, who just published a book last year. So now it's just tracking, "Okay, what are the interviews? What are the media hits? What are the tactics that Charles Oakley used in publishing his book?" We don't go and look at, "Okay. When Michael Jordan published his book or Kobe Bryant published his book." You look at someone that's a very nice comparable in terms of who the person is, in terms of what the book is.Doone Roisin (24:33):Absolutely.Ben Guest (24:34):Speaking of not having to do this on your own, so when this podcast interview drops, I'm also officially putting my shingle out there, Ben Guest Book Consulting.Doone Roisin (24:49):Ready for hire.Ben Guest (24:51):Ready for hire. And Doone has been great. You've already connected me with several people. And again, it's just all organic, it's all just word of mouth, and that's led to a couple of great projects that I'm currently working on. I hate doing this, but if we could do a little bit of promotion, what was it like working with me?Doone Roisin (25:06):Oh, my gosh. First of all, I think your superpower is just making things really easy. You already know the blueprint, the strategy. You've got everything there. And you just fed that to me in a way that I was easily able to be, "Great. I'm busy. I don't have time for lots of different things." You just gave me the list and I was able to work my way through it.Doone Roisin (25:33):And I would say the number one thing was, it was just so easy working with you, which was such joy, such joy in my life. And then I would also say you are a great accountability buddy. You were a cheerleader for me the whole way through. You made me feel really supported. You made me feel really good about myself, and made me feel like I could totally achieve the things that I wanted to achieve, so accountability was second.Doone Roisin (25:58):And then I think also, what was really important was if I just had a quick question, I would just come to you and you would have the answer. It was just so easy having that person that you can... Instead of having to spend time researching and then you don't know if that's really the answer and then you'd ask five people their opinions, I could just be like, "Ben, hey, what do I need to do here?" Yeah. I think working with you was just absolutely amazing and I can't recommend you highly enough. I really loved the process and you made my life easy. You were my accountability buddy, and you were just there when I needed support. You were my support line. But yeah, I had the best time working with you. It was super fun.Ben Guest (26:41):Thank you so much. And it was the same. It was just a joy working with you. And I can't tell people how enjoyable it is to work with someone, and you have your plan and you follow your plan, you execute your plan, and then it succeeds, and it's more successful than you even hoped and envisioned for. But it's all about just going back to those actionable items. I really think that's the key. It's not, "Okay. Here's the plan, and it's just reach out to some podcasts." Right? It's, "Okay. Have your comparable author. Find five podcast interviews they did. What were the podcasts? What's the contact information? Contact these five people." Actionable item that takes all the mystery out of it. You know exactly what you need to do.Doone Roisin (27:31):A hundred percent. Absolutely. And I think the other thing is that you can often feel like, "Oh my God. How am I going to get up to the top of that mountain? That mountain is so high." That just feels not attainable. But then when you've broken it down into all those tiny little steps, it's just the 1% every day that you need to aim for. You just need to tick off one tiny thing or two tiny things, or if you're in a power mode, tick off 10 things. Great, amazing. But that's why you give yourself that three month window where you're just going to chip away every single day. And then when you look back in hindsight, you're going to be like, "Wow. That really compounded because I did all the steps from three months out, and then I'm at the top of the mountain and I don't even know how I got here." It's really that 1%, 1% every day.Ben Guest (28:20):You mentioned being invited to Buckingham Palace and meeting the future king of England. And it was so cool seeing that on your social media. Do you tie that directly to the success of your book?Doone Roisin (28:34):Oh, hell yeah. Yeah. It's just such a wild story.Ben Guest (28:39):Because that was not on our list.Doone Roisin (28:41):Definitely not on the list of goals, going to Buckingham Palace. Yeah, that was so wild. Basically, the book came out, I had a feature go up on Sohohouse.com, which was talking about the book, talking about entrepreneurship. And someone saw that and nominated me for the Young Australian Achiever of the Year Award in the UK. And when I received the email, I didn't know I was nominated or anything like that. But I received an email to say, I'd won this thing. And I was like, "Oh, that's not true. This is a lie. This is spam or whatever." And then I LinkedIn stalked a few people and I was like, "Oh, maybe this is legit." And my family was out here being like, "I don't think this is legit. You need to be careful. If it's Australia House, they'll be contacting you by mail." And I was like, "I don't know." Anyway, it was all a bit weird.Doone Roisin (29:36):And even when we were going, they hosted this huge gala event and I had to get up and give a speech. And there was hundreds of people there. And the person who won Australian of the Year was this amazing woman who was the Lead Statistician who worked on Oxford AstraZeneca vaccine. And even on our way there, I was like, "Maybe this is part of some big scam" or "Oy, is this really real?" And then when we got there, I was like, "Oh, it actually is really real."Doone Roisin (30:06):And then the next thing that happened was after that, not too long after that, I got another email from the Embassy, because Australia House is the Embassy of Australia in London. I got another email from the assistant to the High Commissioner asking if I would be happy for my name to be put forward. But they were very vague and it was something to do with the royals. And I was, again, just shrugged it off, was like, "Oh, whatever."Doone Roisin (30:35):And then, it was so weird. It was such a weird coincidence, because on the Saturday morning at 6:00 AM, my husband and I were going to fly to New York for some work stuff. And on the Friday afternoon, when we walked back into the apartment, we never check our mail, because we have concierge where we receive packages and stuff. We never check our actual letter box. And I was like, "Oh, we haven't checked the letter box in a while. We should just check it." When I opened it up and it's packed to the brim, and on the very top sitting there is a letter from Buckingham Palace. And I was like, "Oh, s**t," because it had been Jubilee Weekend. And I was like, "Oh I bet I've missed the event. I reckon I was invited to just party at the palace or something and it's already gone."Doone Roisin (31:22):And then I opened it, and it was an invitation basically around celebrating people who have contributed to culture and community within the UK and as a result of what I've been building with Female Startup Club and being recognized as the Australian Young Achiever of the Year. And I was like, "Whoa, this is crazy." And it was for that week. And so, I was about to fly the next morning. I would have missed it if I didn't check the letter box, because the event was then on Thursday. So I had to change my flight, went to Buckingham Palace, and I went with Merryn, who is the Lead Statistician who won Australian of the Year.Doone Roisin (31:59):And we just had the best time. It was so cool. I had a few moments with Prince Charles and we were talking about what I was doing with Female Startup Club. And he was making some jokes about the Prince's Trust, because he supports young entrepreneurs and ambitious young people through his organization. And it was just one of those moments that was so weird and so bizarre, so amazing. It was just such a thrill, and yeah, had the best day and then flew to New York and we got to celebrate on a high in New York as well.Ben Guest (32:36):What's Prince Charles like? What's one of the jokes he made?Doone Roisin (32:39):Oh, my God. I can't even remember because I froze. I can't remember the specific things that he said, but he was so charming. Of course, royals, you expect them to be charming and you expect them to be lovely. But when I met him, I was like, "Wow." He deeply looks into your eyes and really gives you the moment to have a little chat and have a little joke. He's so charming and so warm and absolutely lovely. And Camilla was also just wonderful. She was so lovely and kind and very gracious. So yeah, it was really special. I couldn't have ever imagined that Female Startup Club would lead me to Buckingham Palace.Ben Guest (33:24):That's so cool. We started at the top of the interview talking about the ancillary benefits of publishing a book, and it leads to things like speaking gigs and it's really an accelerator, an accelerant for everything else that you're doing. And in this case, it led to being invited to Buckingham Palace. Now I can't promise you if you engage me, if you engage Ben Guest Book Consulting, that you're going to get invited to Buckingham Palace, but I can promise you that you will have a successful book launch.Doone Roisin (33:55):Yes. Everyone should hit you up immediately so they can get their own version of Buckingham Palace on the way.Ben Guest (34:02):I love it. So you can find me at, again, the day this interview drops, my website goes live. It's benguest.net. That has all the services I offer, my rates, testimonials, including a wonderful testimonial from you, Doone. Doone, it's been absolutely a pleasure becoming friends over this past year, getting to know you and working with you on this project. And as I said, it's the reward that I get from seeing how successful this was. It can't be put into words, but it's just been an absolute pleasure working with you.Doone Roisin (34:35):Aww, thanks Ben. You are just absolute joy. It's been such a pleasure working with you, too. And I'm so stoked for this new phase for you and all that you're doing as well. It's so exciting. I'm going to be cheering for you. I'll be your hype girl.Ben Guest (34:52):Love it. Love it. Love it. Please tell everybody the name of the book and where they can find you.Doone Roisin (34:58):Yes. The book is called Your Hype Girl. You can find it on Amazon or buy at my website, femalestartupclub.com. And you can find me at Doone Roisin, which is D-O-O-N-E, R-O-I-S-I-N in all the places. I'm on TikTok. I'm on LinkedIn. I'm on Twitter. I'm on Instagram. I'm all over the shop, so check in with me wherever you want. Always happy to give advice, always happy to answer any follow-up questions, always happy to just chat about what you're up to, would love to.Ben Guest (35:32):Fantastic. Doone, much continued success, and thank you so much.Doone Roisin (35:38):Thanks, Ben.Ben Guest (35:39):So that was my conversation with Doone Roisin. I'm Ben Guest. You can find all of my work at benbo.substack.com. That's benbo.substackcom. Benbo is a family nickname, B-E-N-B-O. And as I mentioned in this interview, I've started a book consulting business. You can find my services and rates at benguest.net. That's benguest.net. I also have some of the books I'm currently working on, testimonials, et cetera. So I think everybody has a book in them, a story to tell, and if you're interested in telling yours, please reach out. You can find me a benguest.net. Have a great day. This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit benbo.substack.com

Bret speaks with Maajid Nawaz was the founding chairman of Quilliam, a counter-extremism think tank that sought to challenge the narratives of Islamist extremists and, until January 2022, was the host of an LBC radio show on Saturdays and Sundays.https://twitter.com/MaajidNawazhttps://odysee.com/@MaajidNawaz*****Find Bret Weinstein on Twitter: @BretWeinstein, and on Patreon.https://www.patreon.com/bretweinsteinPlease subscribe to this channel for more long form content like this, and subscribe to the clips channel @DarkHorse Podcast Clips for short clips of all our podcasts:https://www.youtube.com/channel/UCAWCKUrmvK5F_ynBY_CMlIAAll removed videos can be found on Spotify Video and Odysee: https://open.spotify.com/show/57R7dOcs60jUfOnuNG0J1Rhttps://odysee.com/@BretWeinsteinCheck out the DHP store! Epic tabby, digital book burning, saddle up the dire wolves, and more: http://www.store.darkhorsepodcast.orgTheme Music: Thank you to Martin Molin of Wintergatan for providing us the rights to use their excellent music.*****UNESCO Universal Declaration on Bioethics and Human Rights, Article 6: Consent: https://unesdoc.unesco.org/ark:/48223/pf0000212116Under-30s offered alternative to Oxford-AstraZeneca jab: https://www.bbc.co.uk/news/health-566655170.096% fatality rate – British parliamentary record: https://questions-statements.parliament.uk/written-questions/detail/2021-07-12/31381Pfizer documents on >1200 deaths in first 90 days of vaccine roll-out: https://perma.cc/6W69-9WFTRadical w/Maajid Nawaz, 6 - On Allegations of Involuntary State Euthanasia Using Midazolam: https://odysee.com/@MaajidNawaz:d/Ep6-Radical:9The faces from China's Uyghur detention camps: https://www.bbc.co.uk/news/extra/85qihtvw6e/the-faces-from-chinas-uyghur-detention-campsHillary Clinton Did It: https://www.wsj.com/articles/hillary-clinton-did-it-robby-mook-michael-sussmann-donald-trump-russia-collusion-alfa-bank-11653084709*****American Hartford Gold: Call them at 866-828-1117 or text DARKHORSE to 998899 to get started buying precious metals such as gold and silver.https://www.americanhartfordgold.com/*****Timestamps(00:00) Introduction(02:12) Maajid's vax history and Crimes against Humanity(04:35) Vax issues(09:36) War against humanity(13:25) Importance of relationship in keeping sane(14:08) Sponsor(17:28) Would Bret have predicted their alliance?(19:02) Intelligence and fear(20:50) Disappointment with Academia(24:13) They're coming for your 5-year-old(27:06) Lineage and courage(28:03) Maajid's injection site(32:02) Parents tolerating nonsense(36:38) MMR and Wakefield(39:06) Better Way Conference Debate(43:45) We're at ideological war(50:22) Radical cynicism(53:02) What is going on?(58:49) Guerilla warfare(01:01:03) Fatal flaw in people who see through the nonsense(01:01:57) Evolving myths(01:07:46) Disagreements with Jordan Peterson(01:15:04) Creating new myths(01:19:26) Doctors and pharmacist relationship(01:21:55) Friends who failed during COVID(01:36:08) The IDWSupport the show

In this episode, I talked to Carina Joe, a Senior Scientist at the University of Oxford (AstraZeneca vaccine). Carina shared her experiences on how did she get involved in the vaccine invention and production We explored further on the issue of covid mutation, vaccine nationalism, and Indonesia's vision to develop a vaccine manufacturing hub. Enjoy!

Chefes de estado e autoridades de vários países participaram, nesta sexta-feira, em Nova York, da Assembleia Geral da ONU para discutir como aumentar o esforço coletivo para vacinação de todos os países./ A estratégia é fundamental para acabar com o caráter pandêmico da Covid-19./ O Ministro da Saúde, Marcelo Queiroga, representou o país no encontro a apresentou os resultados positivos da maior campanha de vacinação da história do Brasil, com mais de 160 milhões de brasileiros imunizados com a primeira dose, cerca de 70% da população com o ciclo vacinal completo e 25% com a dose de reforço./ Queiroga defendeu o acesso justo e equitativo de países com menor cobertura vacinal aos imunizantes contra a Covid-19. “Já doamos mais de 5,6 milhões de doses em ações bilaterais e por meio da Covax Facility. Ao longo de 2022, é possível aumentar esse número, em linha com a meta estabelecida pela Organização Mundial da Saúde (OMS). Marcelo Queiroga reforçou a força do Sistema Único de Saúde e a autonomia do Brasil na produção de imunizantes, alcançada graças ao acordo de transferência de tecnologia entre a Universidade de Oxford/Astrazeneca e a Fiocruz./ Nesta semana, as primeiras doses da vacina Covid-19 produzidas totalmente em solo brasileiro foram entregues ao Ministério da Saúde./ Queiroga destacou que o fortalecimento do complexo industrial da saúde é uma das prioridades do governo brasileiro. “O setor privado vem investindo em novas plantas no Brasil. Recentemente, a OMS selecionou o país como hub de desenvolvimento e produção de vacinas de plataforma RNA”. O ministro da Saúde está em agenda nos Estados Unidos desde última quinta-feira./ Queiroga já se reuniu com a diretora da Organização Pan-Americana de Saúde, Carissa Etienne, para falar do fortalecimento da Atenção Primária e da expansão da capacidade de produção de insumos estratégicos de saúde na América Latina e Caribe./ Neste sábado, o encontro é com o presidente e diretor executivo da Fundação de Pesquisa Cardiovascular da Universidade de Columbia, Juan Granada.///

COVID restrictions in many countries have either already ended or are being phased out. Despite the spread of more contagious variants, is it now time to start living with the virus? Or is this a reckless approach when many countries worldwide have limited vaccine supplies and a low take-up rate? On the Sky News Daily podcast with Jonathan Samuels, we are joined by Oxford University professor Teresa Lambe, who is one of the co-developers of the Oxford–AstraZeneca vaccine. Plus, David Nabarro, special envoy on COVID-19 for the World Health Organisation, and Christina Pagel, professor of operational research at University College London. Daily podcast team: Editor - Philly Beaumont Senior podcast producer - Annie Joyce Podcast producers - Soila Apparicio & Rosie Gillot Junior podcast producer - Aishah Rahman Interviews producer - Reece Denton Digital producer - David Chipakupaku Archive - Simon Windsor, Nelly Stefanova & Rob Fellowes

Meet Discovery Maker Mustapha Bittaye, a postdoctoral researcher at the Jenner Institute who helped create the Oxford AstraZeneca vaccine. Born in The Gambia, a scholarship took Mustapha to the UK to study Microbial Proteomics, and from then onwards he has made truly amazing contributions to human health globally. Conor and Dodi examine Mustapha's story, truly brilliant mind, and how he is looking to the future.

Topic: Traditional Toys May Beat Gadgets in Language Development 嬰兒筆電，嬰兒手機，交談農場，這些都是當前推出快速又先進的玩具，許多被當成激發嬰兒語言技能的工具行銷。 Baby laptops, baby cellphones, talking farms — these are the whirring, whiz-bang toys of the moment, many of them marketed as tools to encourage babies' language skills. 不過，新研究報告質疑這類電子玩具是否會使嬰兒跟父母的口頭交流減少，這種交流對認知發展極其重要。 But a new study raises questions about whether such electronic playthings make it less likely that babies will engage in the verbal give-and-take with their parents that is so crucial to cognitive development. 發表於「美國醫學會小兒科學期刊」的該研究報告發現，嬰兒與父母玩廣告中特別宣傳能促進語言發展的電子玩具時，父母說話及對嬰兒發聲的回應，要比玩傳統玩具如積木或閱讀硬頁書時來得少。嬰兒玩電子玩具時發聲也較少。 The study, published in JAMA Pediatrics, found that when babies and parents played with electronic toys that are specifically advertised as language-promoters, parents spoke less and responded less to baby babbling than when they played with traditional toys like blocks or read board books. Babies also vocalized less when playing with electronic toys. 帶領研究的弗拉格斯塔夫北亞利桑納大學傳播科學與溝通障礙副教授安娜．索沙說：「我的直覺是，他們讓嬰兒跟玩具互動，自己退居一邊。」 "My hunch is that they were letting the baby interact with the toy and they were on the sidelines," said Anna V. Sosa, an associate professor of communications science and disorders at Northern Arizona University in Flagstaff, who led the study. 這項研究建立在日漸增多的一些研究結果之上，既有結果顯示電子玩具和電子書可能使父母較少與小孩進行最有意義類型的口語交流。 天普大學心理學教授凱西．赫許帕塞克說：「當使用這類工具與裝置時，父母們就會閉口。你做的是更多行為規範，像是『別碰那』或『做這個』，甚至啥也不做，因為電子書與玩具已代勞了。」赫許帕塞克未參加上述研究，但此前對電子書跟電子形狀分類盒的研究有類似發現。 The study builds on a growing body of research suggesting that electronic toys and e-books can make parents less likely to have the most meaningful kinds of verbal exchanges with their children. "When you put the gadgets and gizmos in, the parents stop talking," said Kathy Hirsh-Pasek, a professor of psychology at Temple University who was not involved in the new study, but who has found similar effects with e-books and electronic shape-sorters. "What you get is more behavioral regulation stuff, like 'don't touch that' or 'do this,' or nothing because the books and toys take it over for you." 她並補充道：「玩玩具應是玩具只占10%，90％由小孩做主，許多這些電子玩具卻是玩具占了90%以上，小孩只能補白。」 索沙說，她對結果感到驚訝。她原本預期一些父母嬰兒組玩某種玩具時說話較多，而其他組則是在玩另種玩具時說較多話。 She added, "A toy should be 10 percent toy and 90 percent child, and with a lot of these electronic toys the toy takes over 90 percent and the child just fills in the blank." Sosa said she was surprised by the results. She had expected some parent-baby pairs would talk more with one type of toy, while others would talk more with another. 然而，結果卻幾乎一致。玩電子玩具時父母平均每分鐘說40字，少於玩傳統玩具的56字，及讀書時的67字。 But the results were consistent almost across the board. When electronic toys were being used, parents said about 40 words per minute, on average, compared with 56 words per minute for traditional toys and 67 words per minute with books. 這是個小型研究，共26個家庭參與，多為受過良好教育的白人家庭。因此研究人員說，若以更大、更多樣化的群體為研究對象，結果可能不同，但這個研究仍值得注意，因為它盡力捕捉現實世界中無研究人員觀看下的居家親子遊戲時間。 The study was small — 26 families — and most were white and educated. So the researchers say the results might be different with a larger and more diverse group. But the study is notable because it sought to capture real world parent-child playtime in their homes without researchers watching. Source article: https://paper.udn.com/udnpaper/POH0067/292769/web/   Next Article   Topic: Boffin Barbie- toy creator honors vaccine co-creator Toy giant Mattel said Wednesday last week it hoped to “inspire the next generation” after creating a model of its iconic Barbie doll in honor of Sarah Gilbert, co-creator of the Oxford/AstraZeneca coronavirus vaccine. 玩具大廠美泰兒公司上週三表示，為表彰牛津／阿斯捷利康冠狀病毒疫苗之共同發明人莎拉‧吉伯特，該公司為其著名產品芭比娃娃開發了新款，希望能「鼓舞下一代」。 Gilbert said she found the news “very strange” but hoped “children who see my Barbie will realize how vital careers in science are to help the world around us.” 吉伯特聽聞此消息，說她覺得「挺怪的」，但希望「看到我的芭比娃娃的孩子們會了解，科學職業對幫助我們周遭的世界是多麼重要」。 “My wish is that my doll will show children careers they may not be aware of, like a vaccinologist.” The toy company created models in honor of five other women in the sciences: US healthcare workers Amy O'Sullivan and Audrey Cruz, Canadian campaigner Chika Stacy Oriuwa, Brazilian researcher Jaqueline Goes de Jesus and Australian medic Kirby White. 「希望我的玩偶會向孩子們展示他們可能不知道的職業，比如說疫苗學家」。 這家玩具公司也設計了其他款式，來表彰五位科學界的女性：美國醫護人員艾米‧奧沙利文及奧黛莉‧克魯茲、加拿大活動人士奇卡‧史岱西‧奧里瓦、巴西研究人員賈克琳‧戈耶思‧德‧杰索斯，以及澳洲醫師克兒比‧懷特。 “Barbie recognizes that all frontline workers have made tremendous sacrifices when confronting the pandemic and the challenges it heightened,” said Lisa McKnight, senior vice president of Barbie and dolls at Mattel. 美泰兒公司芭比娃娃及玩偶部門高級副總裁麗莎‧麥克奈特表示：「芭比肯定所有前線工作人員，在面對疫情大流行及加劇的挑戰時，都做出了巨大犧牲」。 “To shine a light on their efforts, we are sharing their stories and leveraging Barbie's platform to inspire the next generation to take after these heroes and give back.” “Our hope is to nurture and ignite the imaginations of children playing out their own storyline as heroes.” 「為彰顯其努力，我們分享他們的故事，並利用芭比娃娃這平台，來激勵下一代追隨這些英雄並做出回饋」。「我們希望培養及點燃孩子的想像力，讓他們在遊戲扮演角色時，有自己的英雄故事」。Source article: https://www.taipeitimes.com/News/lang/archives/2021/08/09/2003762257   Next Article   Topic: Giant Japanese robot spurs hopes for tourism after virus hit 受病毒衝擊後 巨大的日本機器人為觀光業燃起希望 An 18-metre “Gundam” robot that can walk and move its arms was unveiled in Japan on Monday amid hopes that it will help invigorate tourism hit by COVID-19. 一個18公尺、可以走動及移動手臂的「鋼彈」機器人週一在日本亮相，希望它能幫忙振興受到2019冠狀病毒疾病衝擊的觀光業。 The robot is modelled after a figure in “Mobile Suit Gundam”, a Japanese cartoon first launched in the late 1970s about enormous battle robots piloted by humans. The series spawned multiple spin-offs and toys and gained a worldwide following. 這個機器人仿照「機動戰士鋼彈」其中一款打造，這部日本卡通於1970年代晚期首度發表，描述了由人類操控之大型戰鬥機器人。一系列漫畫催生出多項衍生產品與玩具，並獲得全球關注。 It will be the centrepiece of the Gundam Factory Yokohama, a tourist attraction that opens on Dec. 19 in the port city. 它將是12月19日於橫濱這個港市開張的觀光景點「橫濱鋼彈工廠」最引人入勝的核心。 “I hope this will lead to stimulating tourism demand and revitalising local areas,” Chief Cabinet Secretary Katsunobu Kato told a news conference. 內閣官房長官加藤勝信在記者會說，「我希望這會帶動刺激觀光需求並振興當地。」 Source article:  https://features.ltn.com.tw/english/article/paper/1417730

So far, about 63% of adult Indians have received both the doses of Covid-19 vaccines. And more than 90% have got at least one dose. India has majorly relied on the viral vector vaccine Covishield for its vaccination drive. Over 88% of the doses given out so far have been of Covishield, the Oxford-AstraZeneca vaccine manufactured locally under licence by the Serum Institute of India. Covaxin accounted for just a fraction. The two new vaccines approved for emergency use last month are Serum Institute of India's Covovax and Biological E's Corbevax. With last month's approval, the country now has eight vaccines in its kitty. Apart from the four discussed earlier, the remaining four are -- Sputnik V, ZyCoV-D, Moderna and Johnson and Johnson. Covishield uses the viral vector technology, while Pfizer and Moderna vaccines are based on messenger RNA or mRNA. Vaccination in western countries has been led by mRNA vaccines. Let us see what all vaccine platforms we have - Broadly, there are four types of platforms which are used in making the vaccine worldwide. They are RNA, viral vector, inactivated virus and protein-based platforms. Here, we are discussing the two most popular platforms on which most vaccines have been developed. They are viral vector and mRNA platforms. Let us understand the difference between the two, starting with the viral vector vaccine. But before that, let us understand that coronaviruses are named so because of the crown-like spikes on their surface, called spike protein or S protein. These spike proteins are the most used target for vaccines.  Viral Vector vaccines Now, let us understand what a viral vector vaccine is. It uses a harmless version of a different virus, called a “vector,” to deliver information to the body that helps it protect you. Genetic material from the target virus, in this case the Covid-19 virus, is placed inside the viral vector.  Once it enters a person's cells, it gives the cells instructions to make harmless copies of the spike protein. As the cells display the spike protein on their surfaces, the immune system starts producing antibodies and a type of white blood cells to fight off what it believes is an infection. If a person is later infected from the Covid -19 virus, these antibodies are already there to fight them. The vaccine doesn't contain the Covid -19 virus or the viral vector virus. Moreover, it does not change the DNA in any way. Covishield, Oxford-AstraZeneca, Janssen (J&J) and Sputnik V and Sputnik Lite use this platform. mRNA vaccine While mRNA vaccine uses genetically engineered messenger RNA created in a laboratory to teach our cells how to make a harmless variant of the spike protein that is found on the surface of Covid-19 virus. The presence of a foreign protein triggers a normal immune response, which produces antibodies that protects us from infection if the real virus enters the body. The vaccine is made of mRNA wrapped in a coating called the lipid nano-particle that makes the delivery easy and keeps the body from damaging it. And just like the viral vector vaccine, mRNA vaccine does not contain any virus, so it cannot give you an infection. After the mRNA delivers the instructions, our cells break it down immediately. Pfizer-BioNTech and Moderna use this technology to fight off the virus.  Watch Video

Andrew Marr talks to two of the leading scientists who were at the forefront of research into fighting the spread of Covid-19. Professor Teresa Lambe was one of the Principal Investigators overseeing the Oxford/ AstraZeneca vaccine programme. She co-designed the vaccine and led the pre-clinical studies, as well overseeing the impact on immunity. She will be taking part in this year's Royal Institution Christmas Lectures (to be aired on BBC 4 at 8pm on 28th, 29th and 30th December), alongside Professor Catherine Noakes. As an engineer Noakes is one of a tiny number of specialists worldwide who study ventilation and the spread of airborne diseases. From the beginning of the pandemic she has been instrumental in providing advice on how the virus transmits and the best strategies to control its spread. Covid-19 is a respiratory disease and one of the books on this year's Royal Society prize shortlist is at the centre of revived interest in how we breathe. James Nestor argues, in his book Breath, that humans have lost the ability to breathe correctly, with damaging consequences that reach beyond snoring, asthma and allergies. Drawing on ancient wisdom and the latest scientific studies Nestor highlights the huge benefits from breathing through your nose, rather than your mouth. Producer: Katy Hickman Photo: Professor Catherine Noakes doing a demonstration at the Royal Institution Christmas Lectures 2021

Ros Russell, the Editor of the Evening Standard's Vaccine for the World project, takes over the Tech and Science Daily this week, to bring you the people behind the scenes tackling Covid-19.Today we're joined by Professor Teresa Lambe OBE, co creator of the Oxford/AstraZeneca vaccine. The team at the University of Oxford lept into action to develop a vaccine in January 2020, before the virus reached the UK in March. Professor Lambe tells us about her journey through creating the vaccine ‘on a Friday night', the struggles her team faced and how she felt once she knew that they had successfully created the UK's first coronavirus vaccine. See acast.com/privacy for privacy and opt-out information.

Welcome to The Nonlinear Library, where we use Text-to-Speech software to convert the best writing from the Rationalist and EA communities into audio. This is: Deference for Bayesians, published by John G. Halstead on the Effective Altruism Forum. Most people in the knowledge producing industry in academia, foundations, media or think tanks are not Bayesians. This makes it difficult to know how Bayesians should go about deferring to experts. Many experts are guided by what Bryan Caplan has called ‘myopic empiricism', also sometimes called scientism. That is, they are guided disproportionately by what the published scientific evidence on a topic says, and less so by theory, common sense, scientific evidence from related domains, and other forms of evidence. The problem with this is that, for various reasons, standards in published science are not very high, as the replication crisis across psychology, empirical economics, medicine and other fields has illustrated. Much published scientific evidence is focused on the discovery of statistically significant results, which is not what we ultimately care about, from a Bayesian point of view. Researcher degrees of freedom, reporting bias and other factors also create major risks of bias. Moreover, published scientific evidence is not the only thing that should determine our beliefs. 1. Examples I will now discuss some examples where the experts have taken views which are heavily influenced by myopic empiricism, and so their conclusions can come apart from what an informed Bayesian would say. Scepticism about the efficacy of masks Leading public health bodies claimed that masks didn't work to stop the spread at the start of the pandemic.1 This was in part because there were observational studies finding no effect (concerns about risk compensation and reserving supplies for medical personnel were also a factor).2 But everyone also agrees that COVID-19 spreads by droplets released from the mouth or nose when an infected person coughs, sneezes, or speaks. If you put a mask in the way of these droplets, your strong prior should be that doing so would reduce the spread of covid. There are videos of masks doing the blocking. This should lead one to suspect that the published scientific research finding no effect is mistaken, as has been confirmed by subsequent research. Scepticism about the efficacy of lockdowns Some intelligent people are sceptical not only about whether lockdowns pass the cost-benefit analysis, but even about whether lockdowns reduce the incidence of covid. Indeed, there are various published scientific papers suggesting that such measures have no effect.3 One issue such social science studies will have is that the severity of a covid outbreak is positively correlated with the strength of the lockdown measures, so it will be difficult to tease out cause and effect. This is especially in cross-country regressions where the sample size isn't that big and there are dozens of other important factors at play that will be difficult or impossible to properly control for. As for masks, given our knowledge of how covid spreads, on priors it would be extremely surprising if lockdowns don't work. If you stop people from going to a crowded pub, this clearly reduces the chance that covid will pass from person to person. Unless we want to give up on the germ theory of disease, we should have an extremely strong presumption that lockdowns work. This means an extremely strong presumption that most of the social science finding a negative result is false. Scepticism about first doses first In January, the British government decided to implement ‘first doses first' - an approach of first giving out as many first doses of the vaccine as possible before giving out second doses. This means leaving a longer gap between the two doses - from 12 weeks rather than 21 days. However, the 21 day gap was what was tested in the clinical trial of the Oxford/AstraZeneca vaccine. As a result, we don't ...

From the BBC World Service: Professor Sarah Gilbert, who helped develop the Oxford-AstraZeneca coronavirus vaccine, says more investment is needed now to help prevent future pandemics. Plus: A new gadget dubbed “Earth’s black box” can record 50 years worth of climate data. And, a look at whether green hydrogen could help future-proof climate goals.

Professor Dame Sarah Gilbert, one of the inventors of the coronavirus Oxford/AstraZeneca vaccine, urges governments not to squander preparedness learning to fight future pandemics. We speak to TikTok on Year of 2021 who reveal the popularity of Nathan Evans and PinkPantheress...but is this a career option? Bitcoin bloodbath: crypto limps into Monday after weekend crash. Nasa approves $400 million funding, including human ‘space reef” after ISS dies. Is that a garden shed on the Moon? Chinese rover spots “mystery hut”. Plane powered by liquid hydrogen planned for transatlantic flights. Singer Grimes releases cold break-up track packed with digs at her ex Elon Musk. See acast.com/privacy for privacy and opt-out information.

From the BBC World Service: Professor Sarah Gilbert, who helped develop the Oxford-AstraZeneca coronavirus vaccine, says more investment is needed now to help prevent future pandemics. Plus: A new gadget dubbed “Earth’s black box” can record 50 years worth of climate data. And, a look at whether green hydrogen could help future-proof climate goals.

Videos https://brandnewtube.com/watch/sonia-elijah-interviews-efrat-fenigson-from-israel_Ws1DDYkiqAOXdis.html     https://www.youtube.com/watch?v=GWN2PV4v0lk&t=8s   Researchers find new link between a disrupted body clock and inflammatory diseases RCSI University of Medicine and Health Sciences, November 25, 2021 New research from RCSI has demonstrated the significant role that an irregular body clock plays in driving inflammation in the body's immune cells, with implications for the most serious and prevalent diseases in humans. The circadian body clock generates 24-hour rhythms that keep humans healthy and in time with the day/night cycle. This includes regulating the rhythm of the body's own (innate) immune cells called macrophages. When these cell rhythms are disrupted (due to things like erratic eating/sleeping patterns or shift work), the cells produce molecules which drive inflammation. This can lead to chronic inflammatory diseases such as heart disease, obesity, arthritis, diabetes and cancer, and also impact our ability to fight infection. (NEXT) Social media tied to higher risk of depression Massachusetts General Hospital, November 23, 2021 The latest in a spate of studies investigating links between use of social media and depression suggests the two go hand in hand. The new study follows a yearlong look at social media use and onset of depression among nearly 5,400 adults. None reported even mild depression at the start. But in multiple surveys over 12 months, depression status had worsened in some respondents, the study found. The risk rose with use of three hugely popular social media sites: Snapchat, Facebook and TikTok. None showed any signs of depression at the first survey. But after completing at least one similar follow-up, nearly 9% showed a "significant" increase in scores for depression risk. (NEXT) Havacado or two. Study finds eating lots of the fruit has public health import Randomized controlled trial found that families with high avocado consumption self-reported reduced caloric intake and an overall healthier diet University of California at San Diego, November 29, 2021 In a novel study, researchers conducted a randomized controlled trial comparing the potential health effects between families that consumed a low allotment of avocados (three per week) and families that consumed a high allotment (14 per week) over six months. They found that the high avocado allotment families self-reported lower caloric consumption, reducing their intake of other foods, including dairy, meats and refined grains and their associated negative nutrients, such as saturated fat and sodium. (NEXT) Crabapple supplements could help cut cholesterol, China study discovers Crabapple extract has been show to lower cholesterol in obese mice which were fed a high-fat diet, researchers in China have revealed. Beijing and Shanghai universities, November 30, 2021 The study points out that statins are the major therapy for hypercholesterolaemia and for the prevention of atherosclerosis. However, there is some evidence to suggest that they may increase the risk of diabetes, muscle pain, liver damage and cause other side effects. Crabapple has long been used for the treatment of diarrhoea, indigestion and other digestive diseases in traditional Chinese medicine, and its antioxidant benefits have frequently been studied. (NEXT) Aerobic exercise preserves brain volume and improves cognitive function Wake Forest School of Medicine, November 30, 2021 Using a new MRI technique, researchers found that adults with mild cognitive impairment (MCI) who exercised four times a week over a six-month period experienced an increase in brain volume in specific, or local, areas of the brain, but adults who participated in aerobic exercise experienced greater gains than those who just stretched. (NEXT) Are you a morning or an evening person? It might be due to your gut bacteria University of Haifa (Israel), November 22, 2021 A new study by the University of Haifa reveals that certain gut bacteria differ between morning and evening people. It is already known that there are some genetic differences between larks and owls, but research in fruit flies in our laboratory inspired us to test the impact of gut bacteria on human chronotypes," says Prof. Eran Tauber. Fecal samples were collected from 91 individuals in order to extract and sequence the bacterial DNA. Analysis of the DNA sequences from each sample allowed identification of all gut bacterial species and quantify their abundance. The chronotype of the participants was determined based on their self-reported sleep times during the weekend (waking up without an alarm clock). (OTHER NEXT) Sonia Elijah interviews Efrat Fenigson from Israel Efrat Fenigson, a chief marketing officer and human rights activist from Tel Aviv, Israel, candidly speaks to Sonia about how 'Covid' has been marketed, as if it were a brand, by world governments and the mainstream media. She talks about the general protest movement in Israel and how it evolved from anti-corruption to anti-lockdown/green-pass demonstrations. She gives insight into the psychological state of fear that many Israelis are accustomed to living under making them compliant in obeying the draconian Covid rules and to not question the mass vaccine rollout. (NEXT) Foreclosure Looms for Homeowners Who Thought They'd Won, Thanks to Top New York Court Ruling Sam Mellings The City and New York Focus, November 30, 2021 Christine Fife was “speechless with joy” when she won her foreclosure case in January 2020, she recalled, believing her decade under threat of foreclosure in her Upper West Side condo was finally over. Now, though, Fife is once again facing the seizure of the apartment she has owned since 1990. In February 2021, New York's top court issued a decision that eliminated a path that New York homeowners had used for years to fight foreclosure. The decision in Freedom Mortgage Corporation v. Engel allowed Fife's lender to renew its foreclosure suit against her. “They said it was OK. How can they change their mind?” Fife asked during an interview with New York Focus and THE CITY. Across New York State, homeowners who believed that their cases had been settled in their favor are now once again facing foreclosure due to the Engel decision. Many are in danger of losing their homes, even as two bills aimed at protecting owners wend their way through the state Legislature. Case Reopened In New York, if a borrower misses a mortgage payment, the lender is allowed to demand the entire remaining balance immediately and then move to foreclose after 120 days, if the money owed remains unpaid.. But a lender must start the legal proceedings within six years of first demanding full payment, or the suit becomes invalid. Until recently, the clock kept ticking until the lender informed the borrower that they were no longer seeking foreclosure. In Fife's case, the lender had never done so. The bank sued Fife twice: first in 2010, a case the lender claims it later voluntarily withdrew, and again in 2017. Her lawyers, representing Fife pro bono, successfully argued that the bank's second foreclosure suit was barred by the six-year limit and got it dismissed. But the Engel decision changed the rules. The Court of Appeals found that voluntarily ending a foreclosure suit stops the clock on the six-year time limit — even if the homeowner is never notified. The court's ruling applies retroactively to any foreclosure cases ongoing or still open to appeal at the time the decision was issued. Following the ruling, many foreclosures that expired under the six-year limit have been reopened or appealed to higher courts. Holly Meyer, a Suffolk County lawyer who represented one of the defendants in the Engel case, estimated that the number of affected homeowners could be in the tens of thousands. Fife's was one of them. In April 2021, the bank moved to renew its foreclosure suit against her — and the trial judge cited the Engel ruling as a reason to rehear the case. “I was shocked at this decision, because I had put all my faith in [the foreclosure court's] initial decision, which was in my favor,” Fife said. With Fife's best defense gone, her hopes for avoiding foreclosure now appear slim, her legal counsel acknowledged. ‘Incompetently' Managed Loans It's not uncommon for lenders to allow their right to foreclose to expire, according to real estate lawyers. “There are millions of residential loans being serviced somewhat incompetently, so these things do sometimes slip between the cracks,” said Joshua Stein, a commercial real estate lawyer. Real estate industry supporters of the Court of Appeals' decision say it made little sense for a foreclosure case to fail because of what they consider a clerical error — one that basically lets borrowers shirk their debts. “The idea that you should still be at risk because you haven't repaid the money you borrowed doesn't strike me as egregious,” Stein said. Homeowner attorneys say that cases get dropped all the time in the legal system because of technical violations of procedural requirements, and that foreclosure cases should be no different. “If you have somebody on trial for murder, but you find that their constitutional rights were violated, they go free. It's the same thing here,” Meyer said. Chief Judge Conflicted? The day after the Court of Appeals ruled on the Engel case, the law firm Greenberg Traurig, which had represented two of the plaintiffs, cheered what it called a “ground shifting” victory for lenders. “Statewide application will likely protect billions in assets for mortgage holders,” its press release claimed. Chief Judge Janet DiFiore, who wrote the majority opinion in Engel, was a Greenberg Traurig client at the time that she ruled in favor of their bank clients in that and other cases, the New York Law Journal reported in April. The firm defended her in a suit brought by judges forced into retirement as a cost-cutting measure. Defense attorneys said they had not been informed of the potential conflict for the judge who ruled against their clients. “The law's not on our side anymore, and that means that there are a number of people who will be facing foreclosure when they wouldn't have faced it a couple of years ago,” Julie Howe, a senior staff attorney at the New York Legal Assistance Group, who is representing Fife pro bono, told New York Focus. Then-Governor Andrew Cuomo swears in Janet DiFiore as the new chief judge of the New York State Court of Appeals, Feb. 8, 2016. Governor Andrew Cuomo's Office Jacob Inwald, director of foreclosure prevention at Legal Services NYC, said many of the foreclosure cases affected by the Engel decision originally stemmed from the real estate crash of 2008 and freewheeling lending leading up to it. Fife, for instance, had borrowed $731,000 against her apartment in April 2007 to pay living expenses after a disabling injury and divorce. Monthly payments were nearly $5,000, with adjustable rate mortgage that started at 8% annual interest, potentially rising as high as 15%. “I didn't know anything about mortgages,” Fife said. “I was just so happy that I was able to live on another day. I was probably the easiest take on the block.” Within a year, the bank alleged that she had fallen behind on her mortgage payments — kicking off foreclosure proceedings that her loan's holder, Wilmington Trust Association, has resurrected more than a decade later. ‘It's Really Scary' Rockland County resident Susan Azcuy is in a situation similar to Fife's — believing that she'd survived foreclosure only to find the cloud hanging over her once again. For 23 years, Azcuy and her husband kept up with the mortgage payments on their house in Pomona, including a 2005 refinancing, for which she took on a debt of $210,000 at 5.75% interest. But in 2012, after Azcuy's husband was fired from his job, they missed a payment and their lender quickly moved to foreclose. The bank voluntarily withdrew the suit in March 2016 for technical reasons but did not notify Azcuy, refiling the case the next month. It went to trial in 2019, and Azcuy won, after a key prosecution witness failed to show up. ‘We're still struggling. I was very, very hopeful to be able to continue living here.' Before Engel, this would have been the end of the case, since more than six years had elapsed since the 2012 foreclosure suit. But thanks to Engel, the six-year clock restarted in 2016 — giving Azcuy's lender another chance to sue. Due to penalties and foreclosure fees, Azcuy now owes nearly $400,000, just shy of double the amount of the 2005 refinancing. Efforts to reach a settlement or a modification with the bank have been unsuccessful, according to Azcuy's attorney, Derek Tarson of the Legal Aid Society of Rockland County. If the bank brings another foreclosure lawsuit, which Tarson believes is likely, Azcuy will not be able to rely on the defense that more than six years have passed. “It's really scary. We're still struggling,” Azcuy said. “I was very, very hopeful to be able to continue living here.” Lawmakers Respond State lawmakers have introduced two bills seeking to reverse some of Engel's effects. One measure, sponsored by Sen. Kevin Thomas (D-Nassau) and Assemblymember Helene Weinstein (D-Brooklyn), would require lenders to inform borrowers if they withdraw their demands for payment, since that action serves to stop the clock on the six-year countdown. If lenders withdraw the lawsuit but fail to notify the borrowers, the clock would keep ticking — a return to the status quo before Engel. The bill would also forbid lenders from foreclosing if any part of the loan had previously expired — a measure that would bar reviving suits against homeowners like Fife and Azcuy. The legislature is also considering a second bill, sponsored by Sen. James Sanders (D-Queens) and Assemblymember Latrice Walker (D-Brooklyn). This bill would prevent lenders from discontinuing a demand for full payment, stopping the six-year countdown clock, without the consent of the borrower. The measure also would start the countdown from the time that a mortgage holder missed a payment. Though meant to protect homeowners, the Sanders-Walker bill could actually incentivize lenders to begin foreclosure more quickly, one foreclosure defense attorney told New York Focus. “If the clock is ticking, all plaintiffs are going to want to do is get their case started,” the attorney, who asked not to be named, said. Sanders rejected the critique. “I don't think that you can further incentivize the financial institutions” to foreclose after the leeway granted them by Engel, he said. Whether either of the bills would apply retroactively to homeowners like Fife and Azcuy is an open question. “It may not be able to help those, but it is our desire,” Sanders said. “We will get guidance on whether we can do that.” Sanders said that he has spoken to Gov. Kathy Hochul and legislative leaders about his bill, and while they have not endorsed it, he said they are open to supporting it. (A Hochul spokesperson said the governor “will review all legislation that reaches her desk.” “We are making excellent progress with both, and we expect good things in the coming days,” Sanders said. (NEXT) Israeli study says COVID shot efficacy decreases dramatically after 3 months, calls for boosters British Medical Journal, November 24, 2021 A study published by The BMJ today finds a gradual increase in the risk of COVID-19 infection from 90 days after receiving a second dose of the Pfizer-BioNTech vaccine. The study was carried out by the Research Institute of Leumit Health Services in Israel. Israel was one of the first countries to roll out a large scale COVID-19 vaccination campaign in December 2020, but which has seen a resurgence of infections since June 2021. The findings confirm that the Pfizer-BioNTech vaccine provided excellent protection in the initial weeks after vaccination, but suggest that protection wanes for some individuals with time. To do this, the researchers examined electronic health records for 80,057 adults (average age 44 years) who received a PCR test at least three weeks after their second injection, and had no evidence of previous COVID-19 infection. Of these 80,057 participants, 7,973 (9.6%) had a positive test result. These individuals were then matched to negative controls of the same age and ethnic group who were tested in the same week. The rate of positive results increased with time elapsed since a second dose. For example, across all age groups 1.3% of participants tested positive 21-89 days after a second dose, but this increased to 2.4% after 90-119 days; 4.6% after 120-149 days; 10.3% after 150-179 days; and 15.5% after 180 days or more. (NEXT) 31,014 Deaths 2,890,600 Injuries Following COVID Shots in European Database of Adverse Reactions as Young, Previously Healthy People Continue to Die Health Impact News The European Union database of suspected drug reaction reports is EudraVigilance, and they are now reporting 31,014 fatalities, and 2,890,600 injuries, following COVID-19 injections. A Health Impact News subscriber from Europe reminded us that this database maintained at EudraVigilance is only for countries in Europe who are part of the European Union (EU), which comprises 27 countries. The total number of countries in Europe is much higher, almost twice as many, numbering around 50. (There are some differences of opinion as to which countries are technically part of Europe.) Total reactions for the mRNA vaccine Tozinameran (code BNT162b2, Comirnaty) from BioNTech/ Pfizer: 14,526 deaths and 1,323,370 injuries to 20/11/2021 Total reactions for the mRNA vaccine mRNA-1273 (CX-024414) from Moderna: 8,518 deaths and 390,163 injuries to 20/11/2021 Total reactions for the vaccine AZD1222/VAXZEVRIA (CHADOX1 NCOV-19) from Oxford/AstraZeneca: 6,145 deaths and 1,075,335 injuries to 20/11/2021 Total reactions for the COVID-19 vaccine JANSSEN (AD26.COV2.S) from Johnson & Johnson: 1,825 deaths and 101,732 injuries to 20/11/2021 (NEXT) Censorship = dictatorship Dr. Jessica Rose, November 29, 2021 So the censorship continues. I did a very detailed and informative interview with Frank McCaughey of Ireland on the subject of the pointlessness, potential harms and dangers with mass injecting children during this ‘pandemic' with the known non-sterilizing COVID-19 injectable products. And it has been remove Let's check out what YouTube's Community Guidelines are, shall we? YouTube's Community Guidelines: These determine what content is allowed on YouTube and help make YouTube a safe place to foster community. A safe place to foster community, eh? What kind of community are you thinkin' ‘bout there, Youtube? A community akin to an enslaved, dead-eyed mass of hypnotized automatons? If I may: no thanks on that. I'd rather live on that cat Island. So, for those of you who didn't get to see the video (I imagine that is all of you since it was up for less than 24 hours), I talked at length about the ‘don't's of injecting pre-pubescent children with experimental products for which the ingredient list is a big secret for a ‘disease' that they do not succumb to. Ah, I see now. It was because I mentioned Ivermectin. Boy. Youtube. Get with the program! Read some studies for crying out loud! And update your censorship guidelines! Make them reflect the scientific truth and not the weird false dictates of singular beings who feast on the ‘community' to increase their ‘power'. Here's what I found in their COVID-19 medical misinformation policy. Treatment misinformation: Content that encourages the use of home remedies, prayer, or rituals in place of medical treatment such as consulting a doctor or going to the hospital Content that claims that there's a guaranteed cure for COVID-19 Content that recommends use of Ivermectin or Hydroxychloroquine for the treatment of COVID-19 Claims that Hydroxychloroquine is an effective treatment for COVID-19 Categorical claims that Ivermectin is an effective treatment for COVID-19 Claims that Ivermectin and Hydroxychloroquine are safe to use in the treatment COVID-19 Other content that discourages people from consulting a medical professional or seeking medical advice Ok. I want to work backwards through the italicized points, if I may. 1. Hey Youtube. I AM a medical sciences professional. This IS my consultation. Doesn't that make your dictate of discouraging ‘consulting a medical professional' moot? I am not only not discouraging this, in addition to encouraging this, I am this. 2. Hey Youtube. GET WITH THE PROGRAM. Ivermectin has been affiliated with Nobel-ity. It's not only been awarded a prize for its safe use as an anti-parastic for decades and been doled out to literally billions of people, (including pregnant women and children) with no ill effects, it's has an excessively successful safety profile as an off-label drug in the context of COVID-19.¹ 3. It has also been clinically-tested and proven effective in the context of COVID-19 as an off-label drug - which is more than we can say about the clot shots, eh?²³⁴⁵⁶⁷⁸⁹¹⁰¹¹ 4. Based on points, 1, 2 and 3, I would recommend the off-label use of Ivermectin. As a Medical Scientist. Oh and by the way, aren't you violating your own ‘Community Standards' with your point on a ‘guaranteed cure for COVID-19'? You guys are so sure that your injections are the only way to deal with this situation. Doesn't that imply that this guarantees a cure? No wait. It doesn't. But what it does do is set a precedent and instigate a thought: there will never be a cure for COVID-19. It's incurable. Which is: true. But it's also no worse than the flu in the non-vulnerable, which is most people. Including children. So we don't need to seek a ‘cure'. Just like we don't need to seek a ‘cure' for the common cold or the flu. That's one of the things that our bloody immune systems are for and very good it - preventing disease. Viruses are EVERYWHERE. ALL THE TIME. It's not a reason to freak out. Educate yourself and others on this. It about high time people learned that we are constantly engaging and have co-evolved with viruses and bacteria for the entirety of our existences. It's what we are.¹² Our genome is 7% retrovirus. If we attempt to destroy this magnificence then we are not only stupid, but we will be destroyed in turn. Leave the immune system alone. Or rather, optimize it. Be healthy. Avoid toxins. As much as you can. Pretty simple. So there you are Youtube. You have been brought up-to-date. Now, I don't like simply bitching about stuff, even though it does feel good, so I wanted to bring it to everyone's attention that you can fight to have your content re-instated once it has been removed. However, it is not a common occurrence to have a video re-instated once it has been censored. The ones that do get re-instated typically are ones that were erroneously taken down. I think that the Youtube overlords would argue that since they are paid to enforce the dictate narrative, they cannot stand behind science and truth, and therefore, I think they would hold fast to their ‘claims' that Ivermectin is dangerous and ineffective. (NEXT) Why aren't healthcare workers speaking out about the catastrophe caused by the vaccines? Steve Kirsch, November 23, 2021 Everyone thinks that if the jabs were really dangerous, doctors and other healthcare workers would be speaking out about it. They are wrong. Here are the four main reasons they do not speak out.Two important things you need to know: 1.All the kids were recently vaccinated. 2. Kids that age NEVER get tachycardia (i.e., the medical experts I've talked to have never seen it before in their careers). Here are some reasons very few people are speaking out: 1. Delegated trust. People trust their doctors, the doctors trust other doctors and ultimately the CDC. Nobody is independently verifying the CDC is telling the truth. Doctors are really really bad in critically reading scientific studies. Mask guidelines are the PERFECT example of this. There isn't any scientific proof (well-done randomized trial) that masks work. Yet very few question the narrative (and those that do are ostracized). So everyone basically goes with the flow and the whole thing is a positive feedback loop despite zero scientific basis. See my article Masks don't work and read the accolades in the Nature article. All these experts who hailed the study never read it with a critical eye and lack the skills to do so. This is how misinformation propagates. 2.Fear of job loss. Nobody wants to lose their job. Look what happened to Deborah Conrad and others who speak out. Fired within hours after speaking out. So the lab technicians who are now seeing kids with tachycardia just keep their mouth shut. They know something is very wrong, but their job is more important. Besides, if they spoke out, it wouldn't make any difference since they are just a lab technician. Doctors have a similar problem. The medical system, despite claims of physician autonomy, actually offers very little, as it takes very little to be thrown out of the system. Medicare, the FDA, a state medical board, a malpractice insurer, the DEA, a hospital medical staff, an employer - you only have to cross one of these to have your career ruined. Combine that with the idea that most physicians wouldn't be willing to stand against a medical establishment agency such as the CDC (the ones who will have long since been ostracized) and that to do so would require a huge amount of energy and time spent on medical paper research to make a case (and most docs don't have time for that) and that most of medicine is necessarily a form of group think anyway. Then add on to it that the policy makers in large medical corporations roles are more immediately to protect the interests of the corporation than to "save the world," and you arrive at our current situation. 3.Belief that COVID is even worse than the vaccine injuries. Many people are deceived by erroneous reports that the number of vaccine cases (e.g., of myocarditis) are occurring far less often now that the vaccines have been rolled out. Dr. John Su is the big culprit here because he's never told the world that VAERS is under-reported. The pediatric cardiologists know what is going on, but they aren't going to say anything due to #1. So I see doctors tweeting the myth that “sure, there is myo after the vaccine, but the rates due to COVID are worse so the vaccine is the better of the two options.” 4.Belief that the injuries are really rare. I know a doctor who treats vaccine injured patients. He has no clue whether these are every single vaccine injured patient in the US or he's only seeing a tiny fraction of the injuries. He believes he's seeing them all so writes it off as just “coincidence” and “bad luck” since if it was the vaccine, the CDC would have spotted it. 5. Cognitive dissonance/trust in authority figures. They are so convinced the vaccines are safe (since nobody else is speaking out), that any adverse events that happen must be due to something else. Positive feedback loop. 6.Belief that they can treat you for your vaccine side effects, but that they can't treat you if you have COVID. So lesser of two evils. And of course, they think no early treatments work, so they think they are doing you a favor by telling you to get the vaccine. 7.Belief that there is no viable alternative for treating COVID and that the vaccines work. So even 100,000 dead or injured people is better than 750,000 dead people from COVID. 8. Trust in the NIH and CDC. If it was a problem, the CDC would tell people. Telling people isn't their job. Their job is to follow the direction set by the experts. 9.Fear of being ostracized. People who do research fear if they speak out they would be labelled as anti-vaxers and their research would thus be discredited. 10.Critical thinkers have been fired. Hospitals and medical facilities have already fired vaccine hesitant employees per vaccine mandates thereby self selecting for vax believers. 11. They think that the side-effects show that the vaccine is “working.” This is more of a patient thing. It's how the patients look at their adverse events… as a positive thing. (You really can't make this stuff up.) 12.They are being paid to look the other way. The federal government gave “grants” (aka BRIBES) to hospitals and physicians to promote the vaccines. If they speak out against them now, the government will demand the grants are repaid. [A physician reported this to me on Telegram. You really can't make this stuff up.] 13. They will lose their research funding if they publish their results.

Julia is joined by Professor Dame Sarah Gilbert, the co-creator of the Oxford-AstraZeneca vaccine, one of the most widely used Covid-19 vaccines in the world. She shares her experience of working around the clock with her team to develop the vaccine at record speed, what it's been like to see the impact of the vaccine in the UK and beyond, and her frustration at the inequity of vaccine distribution around the world. Sarah also underlines the need for more funding for vaccine development to ensure we can be better prepared for future outbreaks and avoid the devastating consequences of another global pandemic. See acast.com/privacy for privacy and opt-out information.

11 4 Is Vaxzevria, The Oxford - AstraZeneca Vaccine Safe by WHO Collaborating Center for Vaccine Safety

On this episode I give a detailed description of the Astra/Zeneca COVID-19 Vaccine. Including efficiency, dosing recommendations, side effects etc. --- This episode is sponsored by · Anchor: The easiest way to make a podcast. https://anchor.fm/app Support this podcast: https://anchor.fm/health-facx/support

On New Year's Day 2020, Sarah Gilbert, Professor of Vaccinology at Oxford University, read an article about four people in China with a strange pneumonia. Within two weeks, she and her team had designed a vaccine against a pathogen that no one had ever heard of. Less than 12 months later, vaccination was rolled out across the world to save millions of lives from Covid-19. In this episode of the How To Academy Podcast, Professor Gilbert and her colleague Dr Catherine Green, who led on the manufacturing of the vaccine, join us to separate fact from fiction and explain how they made a highly safe vaccine in record time with the eyes of the world watching. Learn more about your ad choices. Visit megaphone.fm/adchoices

The inside story of the Oxford AstraZeneca vaccine, from two of the leading scientists who created it. This is the story of a race - not against other vaccines or other scientists, but against a deadly and devastating virus. On 1 January 2020, Sarah Gilbert, Professor of Vaccinology at Oxford University, read an article about four people in China with a strange pneumonia. Within two weeks, she and her team had designed a vaccine against a pathogen that no one had ever seen before. Less than 12 months later, vaccination was rolled out across the world to save millions of lives from Covid-19. In Vaxxers, we hear directly from Professor Gilbert and her colleague Dr Catherine Green as they reveal the inside story of making the Oxford AstraZeneca vaccine and the cutting-edge science and sheer hard work behind it. This is their story of fighting a pandemic as ordinary people in extraordinary circumstances. Sarah and Cath share the heart-stopping moments in the eye of the storm; they separate fact from fiction; they explain how they made a safe vaccine in record time with the eyes of the world watching; and they give us hope for the future. Vaxxers invites us into the lab to find out how science will save us from this pandemic, and how we can prepare for the inevitable next one.

Сүүлийн үед хэвлэл мэдээллийн хэрэгслээр Oxford AstraZeneca вакцин хийлгэснээр цусны бүлэн үүсэх хүндрэлийг дагуулдаг хэмээх шар мэдээ хөвөрч байна. 2021 оны вакцин хийлгэсэн тайланд Oxford AstraZeneca вакцины 18.000.000 дээш тун хийхэд цусны бүлэн үүссэн 30 тохиолдол бүртгэгдсэн. Үүнээс улбаалж Герман, Нидерланд, Франц, Канад тэргүүтэй орон дээрх вакциныг ахимаг настай хүмүүст хийхийг түр зогсоосон байдаг. Улмаар Европын Анагаах Ухааны Агентлаг 2021 оны 3 сарын 18 өдөр бол тухайн цусны бүлэн вакцинаас шалтгаалаагүй болно хэмээн мэдэгдсэн. Дээрх 30 цусны бүлэнгийн 22 тохиолдол бол тархины венийн синусын тромбоз эзэлдэг. Тархины венийн судасны тромбоз бол ихэвчлэн цусны бүлэгнэлтийн генетикийн эмгэг, синуситын хүндрэл, гэмтэл, тархины мэс засал зэргээс шалтгаалж үүсдэг.

Basit Türkçe ile Haberler / News in Simple Turkish by skypeturkish.com Bugün 31 Mart 2021 Çarşamba. Basit Türkçe ile Haberler'in yeni bölümüne hoş geldiniz. Kanuni Sultan Süleyman'ın portresi Londra'da açık artırmada satıldı İngiltere'nin ünlü müzayede evi Sotheby's bir açık artırma yaptı. Bu açık artırmada, Kanuni Sultan Süleyman'ın portresi 350 bin sterline, yani yaklaşık 4 milyon 20 bin liraya satıldı. Müzayede evinin komisyonu ile beraber toplam satış fiyatı 438 bin 500 sterlin oldu. Bu fiyat, satıştan önce beklenen fiyattan 4 kat daha yüksek. Portreyi, müzayedeye telefonla katılan bir kişi aldı. Alıcının kimliği açıklanmadı. Rusya'ya gizli belge satan subay gözaltında İtalyan güvenlik güçleri dün akşam Roma'da bir otoparkta operasyon yaptı. Bu operasyonda, İtalyan bir subay, bir Rus askeri yetkilisine gizli belgeler verirken yakalandı. İtalyan donanmasında görevli subay gözaltına alındı. İtalyan basınına göre, subay, askeri belgeler karşılığında 5 bin avro aldı. Rusya'nın Roma Büyükelçiliği'nde görevli iki diplomat bu konu nedeniyle sınır dışı ediliyor, yani İtalya tarafından ülkelerine geri gönderiliyor. Almanya'da Oxford-AstraZeneca aşısı 60 yaş altı için kısıtlandı Almanya, Oxford-AstraZeneca aşısını kısıtlamaya karar verdi çünkü bu aşı 60 yaş üstü kişilerde bazı sorunlara neden oldu. Oxford Üniversitesi ve AstraZeneca şirketi, aşının faydasının çok daha fazla olduğunu savunuyor. Almanya Sağlık Bakanı Jens Spahn, aşılardaki kısıtlamaya rağmen, tüm yetişkinleri yaz sonuna kadar aşılamayı amaçladıklarını söyledi. Anayasa Mahkemesi, HDP iddianamesini eksik buldu Anayasa Mahkemesi, Halkların Demokratik Partisi'nin kapatılması için açılan davayı eksik buldu. Mahkeme, düzeltmeler için davayı geri gönderdi. Anayasa Mahkemesi, düzeltmeler yapıldıktan sonra tekrar toplantı yapacak ve yeni bir karar verecek. Dinlediğiniz için teşekkürler! Yeni bölüm 5 Nisan Pazartesi günü geliyor! If you like this episode, please don't forget to subscribe to our channel. If you are looking for online private Turkish lessons, please visit skypeturkish.com. Görüşürüz!

Passando a Limpo: No programa desta sexta-feira(19), os Estados Unidos planejam enviar cerca de 4 milhões de doses da vacina da AstraZeneca contra a covid-19 que não estão sendo utilizadas. O governo americano deve enviar 2,5 milhões de doses da vacina para o México e 1,5 milhão para o Canadá. O imunizante ainda não foi aprovado para uso nos Estados Unidos. A bancada composta por Igor Maciel, Romoaldo de Souza e Wagner Gomes, debate o assunto com Fabíola Góis, correspondente da Rádio Jornal em Washington (EUA).EUA doará vacinas da Oxford/Astrazeneca para o México e Canadá

En el Rat Pack de este martes, Iván Valenzuela conversó con Paula Comandari, Angélica Bulnes y Andrea Vial sobre el retiro de las vacunas de Oxford-AstraZeneca en varios países de Europa, el sumario por acoso laboral en contra de la presidenta del Tribunal Constitucional y los conflictos entre la banca y el empresario Gonzalo Vial Concha.

LCTRfan discusses the important news of the day:Trouble with the Oxford-AstraZeneca vaccine and the general state of COVID in the worldDemocrat and Pelosi hypocrisy around the Miller-Meeks election challenge in Iowa When will this housing market crash?Explaining the Woke – Wokism and how to spot itMusic by Metre

Passando a Limpo: No programa desta sexta-feira (12), funcionários do governo norte-americano discutem internamente a possibilidade de repassar a outros países, incluindo o Brasil, milhões de doses da vacina de Oxford/AstraZeneca. O imunizante ainda não recebeu autorização para uso emergencial dentro dos EUA, e, segundo o The New York Times, a possibilidade já é considerada pelas autoridades locais. A bancada desta composta por Igor Maciel, Romoaldo de Souza e Wagner Gomes, debate o assunto com Fabíola Góis, correspondente da Rádio Jornal em Washington (EUA).

A 21 year and 7 month sentence has been handed down to Jessica Camilleri for the brutal decapitation murder of her mother Rita in 2019, a Perth mum discovered the body which has been decomposing inside a car for four days, several countries have suspended the use of the Oxford/AstraZeneca jab over fears it could be linked to blood clots, Virgin Australia and Sam Armytage. See omnystudio.com/listener for privacy information.

Hoy volveremos a hablar de vacunación, centrándonos en la "nueva" vacuna de Oxford-AstraZeneca que ya estamos empezando a usar en el programa de vacunación en España. En quién está indicada, cuándo deberían buscarse alternativas, y "sustos" o efectos adversos de la misma. Como siempre, os enlazo algunas webs de interés, en este caso sobre información de las diversas vacunas aprobadas (Pfizer, Moderna y AstraZeneca) y la que se aprobará presumiblemente esta misma semana (Johnson & Johnson): Grupos de vacunación Pfizer/Moderna y AstraZeneca: https://www.mscbs.gob.es/profesionales/saludPublica/prevPromocion/vacunaciones/covid19/docs/COVID-19_Actualizacion4_EstrategiaVacunacion.pdf Fichas técnicas de las vacunas aprobadas en España a 8 de Marzo de 2021: Pfizer: https://www.mscbs.gob.es/profesionales/saludPublica/prevPromocion/vacunaciones/covid19/docs/Guia_Tecnica_COMIRNATY.pdf Moderna: https://www.mscbs.gob.es/profesionales/saludPublica/prevPromocion/vacunaciones/covid19/docs/Guia_Tecnica_vacuna_Moderna.pdf AstraZeneca: https://www.mscbs.gob.es/profesionales/saludPublica/prevPromocion/vacunaciones/covid19/docs/Guia_Tecnica_AstraZeneca.pdf Información sobre la vacuna de Johnson & Johnson: https://espanol.cdc.gov/coronavirus/2019-ncov/vaccines/different-vaccines/janssen.html https://www.nytimes.com/es/interactive/2021/health/johnson-johnson-vacuna-covid.html Podéis encontrarme en:  Facebook: https://www.facebook.com/medciencia  Twitter: https://twitter.com/MedCiencia  Instagram: https://www.instagram.com/drrobertomendez/ Hoy volveremos a hablar de vacunación, centrándonos en la "nueva" vacuna de Oxford-AstraZeneca que ya estamos empezando a usar en el programa de vacunación en España. En quién está indicada, cuándo deberían buscarse alternativas, y "sustos" o efectos adversos de la misma. Como siempre, os enlazo algunas webs de interés, en este caso sobre información de las diversas vacunas aprobadas (Pfizer, Moderna y AstraZeneca) y la que se aprobará presumiblemente esta misma semana (Johnson & Johnson): Grupos de vacunación Pfizer/Moderna y AstraZeneca: https://www.mscbs.gob.es/profesionales/saludPublica/prevPromocion/vacunaciones/covid19/docs/COVID-19_Actualizacion4_EstrategiaVacunacion.pdf Fichas técnicas de las vacunas aprobadas en España a 8 de Marzo de 2021: Pfizer: https://www.mscbs.gob.es/profesionales/saludPublica/prevPromocion/vacunaciones/covid19/docs/Guia_Tecnica_COMIRNATY.pdf Moderna: https://www.mscbs.gob.es/profesionales/saludPublica/prevPromocion/vacunaciones/covid19/docs/Guia_Tecnica_vacuna_Moderna.pdf AstraZeneca: https://www.mscbs.gob.es/profesionales/saludPublica/prevPromocion/vacunaciones/covid19/docs/Guia_Tecnica_AstraZeneca.pdf Información sobre la vacuna de Johnson & Johnson: https://espanol.cdc.gov/coronavirus/2019-ncov/vaccines/different-vaccines/janssen.html https://www.nytimes.com/es/interactive/2021/health/johnson-johnson-vacuna-covid.html Podéis encontrarme en:  Facebook: https://www.facebook.com/medciencia  Twitter: https://twitter.com/MedCiencia  Instagram: https://www.instagram.com/drrobertomendez/

Whitney Webb on the Oxford-AstraZeneca Eugenics Links -The Corbett Report: Interview 1619 - James Corbett https://unlimitedhangout.com/ hitney Webb has been a professional writer, researcher and journalist since 2016. She has written for several websites and, from 2017 to 2020, was a staff writer and senior investigative reporter for Mint Press News. She currently writes for The Last American Vagabond. ----- www.corbettreport.com/ The Corbett Report is an independent, listener-supported alternative news source. It operates on the principle of open source intelligence and provides podcasts, interviews, articles and videos about breaking news and important issues from 9/11 Truth and false flag terror to the Big Brother police state, eugenics, geopolitics, the central banking fraud and more. The Corbett Report is edited, webmastered, written, produced and hosted by James Corbett. James Corbett has been living and working in Japan since 2004. He started The Corbett Report website in 2007 as an outlet for independent critical analysis of politics, society, history, and economics. Since then he has written, recorded and edited thousands of hours of audio and video media for the website, including a podcast and several regular online video series. He is the lead editorial writer for The International Forecaster, the e-newsletter created by the late Bob Chapman. His work has been carried online by a wide variety of websites and his videos have garnered over 50,000,000 views on YouTube alone. His satirical piece on the discrepancies in the official account of September 11th, “9/11: A Conspiracy Theory” was posted to the web on September 11, 2011 and has so far been viewed nearly 3 million times. For more information about Corbett and his background, please listen to Episode 163 of The Corbett Report podcast, Meet James Corbett: Episode 163 – Meet James Corbett Broc West has been the Video Editor of The Corbett Report since December 2014. He currently lives in Southern Vietnam. Twitter: @brocwest Audio taken from: https://www.corbettreport.com/interview-1619-whitney-webb-on-the-oxford-astrazeneca-eugenics-links/

Passando a Limpo: No programa desta quarta-feira(24) Para dar continuidade ao plano de imunização contra a covid-19, Pernambuco recebeu, do Ministério da Saúde, mais 82 mil doses de vacinas Oxford/AstraZeneca, importadas pela Fiocruz do Instituto Serum, na Índia. A bancada composta por Fernando Castilho, Igor Maciel e Wagner Gomes debate o assunto com André Longo, secretário de Saúde de Pernambuco.

La vacuna de Oxford-AstraZeneca pausó los ensayos clínicos el 6 de setiembre debido a la “inexplicable” enfermedad de una de sus participantes. Dichos ensayos reanudaron al determinarse que el caso no se trataba de un efecto secundario de la vacuna tras la evaluación de un comité independiente. Ahora la Agencia Nacional de vigilancia Sanitaria (Anvisa) de Brasil ha informado de la muerte de un voluntario durante el estudio de la vacuna de Oxford en el país. Elmer Huerta entrevista al Dr. Juan More, investigador de la UNMSM (Universidad Nacional Mayor de San Marcos) y PHD en inmunología comparada para arrojar más luz en este tema de los ensayos clínicos.

No podcast ‘Notícia No Seu Tempo’, confira em áudio as principais notícias da edição impressa do jornal ‘O Estado de S. Paulo’ desta quarta-feira (17/02/21): A falta de imunizantes contra a covid-19 está fazendo com que capitais e diversas outras cidades do País suspendam a vacinação menos de um mês após o início da campanha. A Frente Nacional de Prefeitos (FNP) cobrou do governo federal um cronograma de abastecimento e de metas de vacinação para cada faixa de público. O Ministério da Saúde recebeu, no total, 10,7 milhões de doses de vacinas, sendo 8,7 milhões da CoronaVac e 2 milhões do imunizante Oxford/AstraZeneca. Pressionada, a pasta formalizou ontem a compra de 54 milhões de doses da CoronaVac. E mais: Metrópole: Araraquara tem colapso na saúde mesmo com lockdown Política: Base na Câmara quer limitar atos da oposição Economia: Economistas apontam risco de recessão Internacional: Índia reduz casos e intriga cientistas Esportes: Crespo chega e estranha o ‘assédio’ Na Quarentena: A história de Billie Holiday em coresSee omnystudio.com/listener for privacy information.

Recorded February 12, 2021Current Episodes at https://walkinverse.buzzsprout.com/I am moving all podcast here slowly. I will keep buzzsprout for all public reports and here for member only content.Report #37, "Gates, Fauci, and Operation Warp Speed: It's All About Connections." In the last report, we reviewed the mRNA experimental injectable technology. Now we will show a few connections behind it. Grab a pen and notebook and enjoy the report.In the last report, we reviewed the mRNA experimental injectable technology. Now we will show a few connections behind it.To date, health officials claim the novel COVID-19 soars past 16.2 million cases for a virus with a 99.9% survival rate. To justify case count, they continue to use a test proven to produce false positives. This immoral act allows for compliance through fear as these elites can accelerate their agenda without resistance.But before we dig further, please hear these words and wipe the dread from your mind. We will prevail once we remove our eyes from man and place them on the Almighty.And as stated in Isaiah 35:3-5, we have nothing to fear.“Strengthen the weak hands, And make firm the feeble knees. 4 Say to those who are fearful-hearted, “Be strong, do not fear! Behold, your God will come with vengeance, With the recompense of God; He will come and save you.” 5 Then the eyes of the blind shall be opened, And the ears of the deaf shall be unstopped.”Isa 35:3-5With those words in mind, let's view the network which drives the mRNA agenda.Many question why government officials and healthcare providers push an experimental genome therapy labeled a vaccine. They realize it causes illness and death. They have no discernment of long or short-term side effects. And yet, the answer lies before us. Massive financial gain and control for continuous revenue streams at our expense.In an interview, Bill Gates boasted how the vaccine industry returned a 20-1 investment. This statement shows how these elites play for keeps. They do not have our well-being in mind (1).And soon, a Gates-backed (2) firm will release 200 million vaccine kits and millions of experimental injections for vaccination against a coronavirus, aka a common cold.Back in May, Korea's S.K. Bioscience pharmaceutical company received $3.6 million in research funds from the Gates Foundation to support the development of a COVID-19 vax. This same company works as a contract manufacturer for AstraZeneca, which received $750 million from CEPI and GAVI (3) back in June 2020 to support the manufacturing, procurement, and distribution of mRNA injectable technology. In addition, AstraZeneca agreed to supply 1-Billion doses to low and mid-income nations. On top of these quantities, they announced a supply of 400 million doses ready for the E.U. And all the while, under the cover of night, the Imperial College steps into the vaccine game. They plan on another variation by the first half of 2021. Will it work? They have no clue. Professor Robin Shattock (4), the head of the vaccine development team at the University of Imperial College, stated, “We anticipate if everything goes really well, that we'll get an answer as to whether it works by early next year.”Professor Shattock is from the same Imperial College where Neil Ferguson used his fraudulent models to lock the world down (5) through data manipulation. He used invalid inputs based on early estimates. He selected outdated demographics, populations, and hospital bed counts to inflate numbers artificially. Instead of data from specific states to gather credible metrics, his models used the entire U.S. to drive COVID-19 spread. This skyrocketed infection rates and fears, as the model assumed everyone spreads the disease at the same rate—for virus spread detection, it's an outright scam and a crime against humanity. Yet, he still roams free without consequence. Why?The answer lies in the secure funds received from the European Commission, Bill and Melinda Gates Foundation, Wellcome Trust, MRC, and the NIH (Anthony Fauci), which indicates the degree of corruption imposed upon humanity for long term profits.And when we look to NIH and Fauci, we witness extended deception with their ties to Moderna (6). With the mRNA-1273 experiment, the U.S. government appears to have joint ownership through filed patents. With $472 million secured, Moderna plans to reach its target of 500 million doses per year, with a ramp-up to one billion in 2021. Also, (7) DARPA joins Moderna to develop an implantable biochip for the deployment of experimental therapies, which can affect human DNA.But at (8) $19.50 per dose, subsidized by taxpayers, does it matter? It's all about people over profits, which circles us back to GAVI, the WHO, CEPI, and Trump's Operation Warp Speed.Trump pulled finances (9) from the WHO, which everyone cheered as he handed it over to GAVI, the Vaccine Alliance. What most may not realize, Gates and his foundation founded GAVI in 2000 (10). So when Trump pledged $1.16 billion at the virtual Global Vaccine summit, this became part of the Fiscal budget for 2020-2023, which solidified the fact he did not have the American people's best interest in mind. Instead, he increased the hold Bill Gates has on the U.S. population and their health.At the summit, Gates stated, “Since its inception GAVI has helped vaccinate more than three-quarters of a billion children … And now, it's stepping up and saying it's willing to deliver a COVID-19 vaccine as soon as one is available to end the pandemic as soon as possible, … We must also renew our commitment to delivering every life-saving vaccine there is to every child on earth.”In addition, GAVI received a donation of $5 million from the Rockefeller Foundation for “routine immunization programs” and “play a major role in the rollout of a future COVID-19 vaccine.” which aligns with their playbook, Operation Lockstep (11).On top of this, who did Trump put at the helm of Operation Warp Speed? Another Gates connection, a former executive of GlaxoSmithKline, Moncef Slaoui. His role? Work hand in hand with General Gustave Perna for the production and vaccination across the United States.Now we'll look at CEPI, Operation Warp Speed, and Novavax. In 2017 Gates co-founded, “The Coalition for Epidemic Preparedness Innovations (CEPI)” (12) to stop epidemics via vaccines. It's the largest vaccine charity in the world. They made their mark across mainstream when they granted $388 million to an unknown biotech company, Novavax. Another company to fill the world with mRNA injections for COVID-19 (Certificate of Vaccine Identification – Artificial [1] Intelligence [9]). In a move that baffled many, Operation Warp Speed (12) also selected this company and awarded them $1.6 billion in taxpayers' funds. So while the people of the United States have their rights revoked and business destroyed at astronomical rates, the Trump administration gave your future away to Gates for an injection never used or tested on humans.And all the while, the media, Fauci, Gates, social media companies, politicians, and others lied outright to the people about HCQ (13). They knew it worked from day one. But as we see from facts, Big Pharma revenue streams and kickbacks outweighed our health.Instead of protecting people's lives, our officials schemed with these monsters behind closed doors to push an experiment to alter your DNA (14). As learned in Professor Klungland's research, “RNA has a direct effect on DNA stability.” He notes how several research groups collaborate to understand the effects this can have on the DNA molecule. He stated, “We already know that R-loop areas are associated with sequences of DNA containing active genes and that this can lead to chromosomal breakage and the loss of genetic information…” This reveals absolute modification, regardless of what the fake fact-checkers, mainstream, social media channels, or Fauci's pundits claim.To drive this point one step further, we look to the National Cancer Institute for clarification (15). Through research, they learned modification in human mRNA affects gene expression, “NAT10, an enzyme, was found to be responsible for the modification, which itself has been implicated in cancer and aging. This is one of the first examples of a unique chemical modification to mRNA…”To date, these companies refuse doctors and researchers the information required to learn the effects these synthetic drugs have on the human body. But it looks like another revenue stream in cancer therapies with the chemical modification seen in these experiments.And while the PREP Act combined with the unlawful classification of mRNA as a vaccine, these corporations have 100% immunity from all legal action (8) while they engage in an experiment without the people's informed consent (16) — a process which requires compliance or rejection of a medical procedure such as surgeries, anesthesia, radiation, chemotherapy, vaccination, and other scenarios.These experimental war crimes continue under the guise of trials (17), “A new vaccine trial is underway in the U.K. to test whether mixing and matching different COVID-19 vaccines for the first and second doses is effective,” they continue, “The country is currently using the Pfizer-BioNTech vaccine and Oxford-AstraZeneca vaccine, which both require two doses. For the study, run by the National Immunization Schedule Evaluation Consortium, patients will get one dose of each.”Remember, they never approved mRNA technologies for human use. These professionals for profit don't know or care about the long or short term side effects. To further prove these drugs still exist in the experimental stage, Moderna started on July 27, 2020, and will end on October 27, 2020, as noted by the study (18), “A Study to Evaluate Efficacy, Safety, and Immunogenicity of mRNA-1273 Vaccine in Adults Aged 18 Years and Older to Prevent COVID-19.” Pfizer (19) began their test on humanity on April 29, 2020, with a target primary completion on August 3, 2021, and the experiment to end on January 21, 2023, as noted in the “Study to Describe the Safety, Tolerability, Immunogenicity, and Efficacy of RNA Vaccine Candidates Against COVID-19 in Healthy Individuals.”With each injection, they test their poisons on an ill-informed public. And due to PREP, if you or your loved one becomes injured or dies from these jabs, you have zero recourse. Without informed consent, all involved in administration, production, delivery, and procurement—guilty of war crimes against humanity as stated in the Nuremberg Code (20), “The voluntary consent of the human subject is absolutely essential.” No bribes or coercion—all the facts known beforehand. For those front line workers, LEO, Military, Politicians who follow orders, no excuse. During the trials of Nuremberg, ignorance did not afford reprieve from the consequences of their willful actions. They knew and still tested on humans without consent (21).“THE PROOF AS TO WAR CRIMES AND CRIMES AGAINST HUMANITYJudged by any standard of proof the record clearly shows the commission of war crimes and crimes against humanity substantially as alleged in counts two and three of the indictment. Beginning with the outbreak of World War II criminal medical experiments on non-German nationals, both prisoners of war and civilians, including Jews and “asocial” persons, were carried out on a large scale in Germany and the occupied countries. These experiments were not the isolated and casual acts of individual doctors and scientists working solely on their own responsibility, but were the product of coordinated policy-making and planning at high governmental, military, and Nazi Party levels, conducted as an integral part of the total war effort. They were ordered, sanctioned, permitted, or approved by persons in positions of authority who under all principles of law were under the duty to know about these things and to take steps to terminate or prevent them.”Sounds familiar?When Governments (8) and officials receive kickbacks and taxpayers fund Big Pharma experiments with no legal ramifications, it no longer about one health. It's all profits.The time's at hand to end this experiment, or they will end us—no more compliance.There are more of us than them.References* Freedom Lovers TV. 2020. Bill Gates Confesses Vaccines Are His Best Investment w/ ROI of 20 to 1.* Soo Kim. 2020. “Coronavirus Vaccine Update as Bill Gates-Backed Firm Could Make 200 Million Kits a Year.” Newsweek, July 27, 2020, sec. News.* Staff. 2020. “AZD1222 SARS-CoV-2 Vaccine.” Precision Vax. December 6, 2020.* Imperial College. n.d. “Professor Robin Shattock.”* Osburn, Madeline. 2020. “Inaccurate Virus Models Are Panicking Officials Into Ill-Advised Lockdowns.” The Federalist. March 25, 2020.* Patrick Howley. 2020. “BUSTED: NIH Owns Financial Stake In Gates-Funded Coronavirus Vaccine.” National File (blog). June 29, 2020.* Franz Walker. 2020. “DARPA Funded Implantable Biochip Can Potentially Be Used to Deploy Moderna's MRNA Vaccine.” Nanotechnology News. October 12, 2020.* Apuzzo, Matt, and Selam Gebrekidan. 2021. “Governments Sign Secret Vaccine Deals. Here's What They Hide.” The New York Times, January 28, 2021, sec. World.* Broze, Derrick. 2020. “Vaccine Bait & Switch: As Millions Pulled From WHO, Trump Gives Billions To Gates-Founded GAVI.” The Last American Vagabond (blog). July 7, 2020.* The Bill & Melinda Gates Foundation [Internet]. [cited 2021 Feb 9]. Available from: https://www.gavi.org/investing-gavi/funding/donor-profiles/bill-melinda-gates-foundation* N/A. Operation Lockstep: From The Rockefeller Playbook [Internet]. Shadaily. 2020 [cited 2020 Dec 7].* Carmichael, Taylor. 2020. “Why Was Novavax Awarded Almost $2 Billion in Free Money?” The Motley Fool. July 22, 2020.* Patrick Howley. 2020. “EXPOSED: The Truth About Fauci and Birx, Bill Gates And Globalist Elites.” National File. March 26, 2020.* Eyrun Thune. 2020. “Modified RNA Has a Direct Effect on DNA.” PHYS.ORG. January 29, 2020.* NIH. 2018. “A Novel MRNA Modification May Impact the Human Genetic Code.” Center for Cancer Research. November 15, 2018.* Kirsten Nunez. 2019. “Informed Consent in Healthcare: What It Is and Why It's Needed.” Healthline. October 11, 2019.* O'Kane, Caitlin. 2021. “U.K. Study Will Test If Getting Doses of Two Different COVID-19 Vaccines Is Effective.” CBS News. February 4, 2021.* ModernaTX, Inc. 2020. “A Phase 3, Randomized, Stratified, Observer-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Immunogenicity of MRNA-1273 SARS-CoV-2 Vaccine in Adults Aged 18 Years and Older.” Clinical trial registration NCT04470427. clinicaltrials.gov.* BioNTech SE. 2021. “Study to Describe the Safety, Tolerability, Immunogenicity, and Efficacy of RNA Vaccine Candidates Against COVID-19 in Healthy Individuals.” Clinicaltrials.Gov. February 9, 2021.* Government. 2020. “THE NUREMBERG CODE.” February 16, 2020.* Government. 1949. “TRIALS  OF WAR CRIMINALS  BEFORE THE  NUERNBERG MILITARY TRIBUNALS  UNDER  CONTROL  COUNCIL LAW No. 1.” 1949. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit walkinverse.substack.com/subscribe

Passando a Limpo: A farmacêutica AstraZeneca, que desenvolve uma das vacinas experimentais contra Covid-19 em paceria com a Universidade Oxford, afirmou ter encontrado a "fórmula vencedora" sem falhas na eficácia contra as formas graves da doença causada pelo coronavírus (Sars-CoV-2). A bancada desta segunda-feira (28) - composta por Igor Maciel, Ivanildo Sampaio e Jamildo Melo - debateu o assunto com a epidemiologista Ethel Maciel.

Stocks advanced on Monday, with encouraging developments in the fight against COVID-19 providing impetus that carried major benchmarks within view of new record highs. Wall Street added to recent gains as investors weigh a wave of new COVID-19 infections — which are pushing up deaths and hospitalizations across the U.S. — against the rapidly unfolding timetable for the deployment of a vaccine.

https://groupdiscover.com https://patreon.com/timtruth Live shows: https://dlive.tv/timtruth --- Support this podcast: https://anchor.fm/tim-truth/support

While the Russian Sputnik V vaccine follows a similar path as the Oxford-Astrazeneca vaccine of being based on the human adenovirus, a common cold virus fused with the spike protein of Sars-Cov-2 to stimulate an immune response, its approval and registration without the crucial Phase III trial and consequent tie-up with Dr Reddy's Laboratories has made headlines. Manu Balachandran, author of this fortnight's cover story delves into GV Prasad and Dr Reddy's long-standing relationship with Russia, the country's apparent transparency with the pharma company, and why it bet on the controversial vaccine